x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934. |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
Delaware (State or other jurisdiction of incorporation or organization) | 20‑5530657 (I.R.S. Employer Identification Number) |
Large accelerated filer ¨ | Accelerated filer ¨ | Non‑accelerated filer x (Do not check if a smaller reporting company) | Smaller reporting company ¨ |
Page | |
• | our limited operating history, particularly as a newly public company, which makes it difficult to evaluate our current business and future prospects; |
• | our ability to achieve or sustain profitability; |
• | the effects of increased competition in our market and our ability to compete effectively; |
• | our ability to attract new customers or increase the allocation of our existing customers' marketing spend to us; |
• | changes in our customers' advertising budget allocations, agency affiliations or marketing strategies; |
• | our ability to develop new products and services, enhance our existing products and services or make necessary changes to our technology platform or business model; |
• | our ability to expand our business internationally; |
• | our ability to comply with, and the effect on our business of, evolving legal standards and regulations, particularly concerning privacy and data protection; |
• | the seasonality of our business; |
• | our dependence on the continued growth of the digital advertising market; |
• | our ability to maintain a supply of media inventory or impressions; |
• | our ability to retain key employees and attract additional key employees; |
• | our ability to maintain effective internal controls; |
• | our recognition of revenue from customer subscriptions over the term of the customer agreements; and |
• | general market, political, economic and business conditions, including internationally. |
As of December 31, | As of September 30, | ||||||
2015 | 2016 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 41,143 | $ | 24,122 | |||
Accounts receivable, net | 43,336 | 35,147 | |||||
Prepaid expenses and other current assets | 1,246 | 1,974 | |||||
Restricted cash, short-term | 1,861 | — | |||||
Total current assets | 87,586 | 61,243 | |||||
Property, equipment and software, net | 19,385 | 20,058 | |||||
Other long-term assets | 315 | 57 | |||||
Total assets | $ | 107,286 | $ | 81,358 | |||
Liabilities and Stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 14,987 | $ | 10,164 | |||
Accrued expenses and other current liabilities | 8,386 | 9,310 | |||||
Short-term debt | 31,225 | 26,125 | |||||
Total current liabilities | 54,598 | 45,599 | |||||
Other long-term liabilities | 955 | 1,280 | |||||
Total liabilities | 55,553 | 46,879 | |||||
Commitments and contingencies (See Note 7) | |||||||
Stockholders’ equity: | |||||||
Common stock, $0.00005 par value; 500,000,000 shares authorized, 6,560,987 and 6,605,137 shares issued and outstanding as of December 31, 2015 and September 30, 2016, respectively | 1 | 1 | |||||
Additional paid-in capital | 103,114 | 106,305 | |||||
Accumulated other comprehensive loss | (82 | ) | (179 | ) | |||
Accumulated deficit | (51,300 | ) | (71,648 | ) | |||
Total stockholders’ equity | 51,733 | 34,479 | |||||
Total liabilities and stockholders’ equity | $ | 107,286 | $ | 81,358 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
Revenue | $ | 35,969 | $ | 37,418 | $ | 99,135 | $ | 102,807 | |||||||
Traffic acquisition costs | 12,935 | 12,489 | 38,053 | 35,352 | |||||||||||
Other cost of revenue | 4,280 | 5,135 | 10,863 | 14,710 | |||||||||||
Gross profit | 18,754 | 19,794 | 50,219 | 52,745 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 12,883 | 11,182 | 38,521 | 37,736 | |||||||||||
Research and development | 6,127 | 7,083 | 16,206 | 20,671 | |||||||||||
General and administrative | 4,347 | 4,188 | 11,442 | 13,889 | |||||||||||
Total operating expenses | 23,357 | 22,453 | 66,169 | 72,296 | |||||||||||
Loss from operations | (4,603 | ) | (2,659 | ) | (15,950 | ) | (19,551 | ) | |||||||
Other expense (income): | |||||||||||||||
Interest expense | 190 | 261 | 1,060 | 761 | |||||||||||
Interest income | — | — | — | (3 | ) | ||||||||||
Amortization and write-off of debt discount | — | — | 1,108 | — | |||||||||||
Amortization and write-off of deferred financing costs | 8 | 11 | 189 | 39 | |||||||||||
Derivative fair value adjustment related to common stock warrants | — | — | (482 | ) | — | ||||||||||
Total other expense | 198 | 272 | 1,875 | 797 | |||||||||||
Loss before income taxes | (4,801 | ) | (2,931 | ) | (17,825 | ) | (20,348 | ) | |||||||
Provision for income taxes | — | — | — | — | |||||||||||
Net loss | $ | (4,801 | ) | $ | (2,931 | ) | $ | (17,825 | ) | $ | (20,348 | ) | |||
Net loss per basic and diluted share of common stock | $ | (0.74 | ) | $ | (0.44 | ) | $ | (3.50 | ) | $ | (3.09 | ) | |||
Weighted-average shares used to compute net loss per basic and diluted share of common stock | 6,485,755 | 6,599,233 | 5,089,110 | 6,582,118 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
Net loss | $ | (4,801 | ) | $ | (2,931 | ) | $ | (17,825 | ) | $ | (20,348 | ) | |||
Other comprehensive loss: | |||||||||||||||
Foreign currency translation adjustments | (22 | ) | (22 | ) | (14 | ) | (97 | ) | |||||||
Comprehensive loss | $ | (4,823 | ) | $ | (2,953 | ) | $ | (17,839 | ) | $ | (20,445 | ) |
Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Stockholders’ Equity | ||||||||||||||||||
Shares | Amount | |||||||||||||||||||||
Balance—January 1, 2016 | 6,560,987 | $ | 1 | $ | 103,114 | $ | (82 | ) | $ | (51,300 | ) | $ | 51,733 | |||||||||
Exercise of stock options | 29,875 | — | 106 | — | — | 106 | ||||||||||||||||
Issuance of common stock under employee stock purchase plan | 29,493 | — | 202 | — | — | 202 | ||||||||||||||||
Repurchases of common stock | (15,197 | ) | — | (125 | ) | — | — | (125 | ) | |||||||||||||
Extinguishment of fractional shares resulting from reverse stock split | (21 | ) | — | — | — | — | — | |||||||||||||||
Stock-based compensation | — | — | 3,008 | — | — | 3,008 | ||||||||||||||||
Foreign currency translation adjustments | — | — | — | (97 | ) | — | (97 | ) | ||||||||||||||
Net loss | — | — | — | — | (20,348 | ) | (20,348 | ) | ||||||||||||||
Balance—September 30, 2016 | 6,605,137 | $ | 1 | $ | 106,305 | $ | (179 | ) | $ | (71,648 | ) | $ | 34,479 |
Nine Months Ended September 30, | |||||||
2015 | 2016 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (17,825 | ) | $ | (20,348 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 4,270 | 7,137 | |||||
Stock-based compensation expense | 2,756 | 2,678 | |||||
Change in fair value of warrants | (482 | ) | — | ||||
Bad debt expense | 177 | 324 | |||||
Loss on disposal of asset | — | 4 | |||||
Amortization and write-off of debt discount | 1,108 | — | |||||
Amortization and write-off of deferred financing costs | 189 | 39 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 6,855 | 7,802 | |||||
Prepaid expenses and other current assets | (1,038 | ) | (608 | ) | |||
Security deposits | (41 | ) | (19 | ) | |||
Accounts payable | (5,611 | ) | (5,150 | ) | |||
Accrued expenses and other current liabilities | 4,653 | 888 | |||||
Other long-term liabilities | 570 | 325 | |||||
Net cash used in operating activities | (4,419 | ) | (6,928 | ) | |||
Cash flows from investing activities: | |||||||
Purchases of property, equipment and software | (6,069 | ) | (1,754 | ) | |||
Capitalized internal-use software costs | (4,721 | ) | (5,181 | ) | |||
Changes to restricted cash | 563 | 1,861 | |||||
Net cash used in investing activities | (10,227 | ) | (5,074 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from the issuance of common stock in initial public offering, net of underwriting discounts and commissions | 69,518 | — | |||||
Payments of costs related to initial public offering | (2,304 | ) | — | ||||
Proceeds from debt | 10,225 | 3,400 | |||||
Repayment of debt | (27,500 | ) | (8,500 | ) | |||
Proceeds from stock option exercises | 684 | 106 | |||||
Proceeds from issuance of common stock under employee stock purchase plan | — | 202 | |||||
Payments for repurchases of common stock | — | (125 | ) | ||||
Payments of issuance costs related to debt | (57 | ) | (54 | ) | |||
Net cash provided by (used in) financing activities | 50,566 | (4,971 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (5 | ) | (48 | ) | |||
Net increase (decrease) in cash and cash equivalents | 35,915 | (17,021 | ) | ||||
Cash and cash equivalents at beginning of period | 12,949 | 41,143 | |||||
Cash and cash equivalents at end of period | $ | 48,864 | $ | 24,122 |
Nine Months Ended September 30, | |||||||
2015 | 2016 | ||||||
Supplemental disclosures of other cash flow information: | |||||||
Cash paid for interest | $ | 1,245 | $ | 805 | |||
Supplemental disclosures of non-cash investing and financing activities: | |||||||
Purchases of property, equipment and software included in accounts payable and accruals | $ | 2,527 | $ | 419 | |||
Additions to property, equipment and software from other long-term assets | $ | — | $ | 213 | |||
Stock-based compensation capitalized in internal-use software costs | $ | — | $ | 330 | |||
Issuance costs related to debt included in accounts payable and accruals | $ | — | $ | 56 | |||
Vesting of restricted stock subject to repurchase | $ | 57 | $ | — | |||
Issuance of lender warrants allocated to debt discount | $ | 335 | $ | — | |||
Conversion of convertible preferred stock to common stock | $ | 25,476 | $ | — | |||
Warrant derivative liability reclassified to additional paid-in capital | $ | 1,132 | $ | — | |||
Liability-based option awards reclassified to additional paid-in capital | $ | 288 | $ | — | |||
Deferred offering costs reclassified to additional paid-in capital | $ | 3,782 | $ | — |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
Allowance for doubtful accounts: | |||||||||||||||
Balance, beginning of period | $ | 159 | $ | 315 | $ | 179 | $ | 102 | |||||||
Add: adjustment for bad debts | 177 | (4 | ) | 177 | 324 | ||||||||||
Less: write-offs, net of recoveries | (13 | ) | (1 | ) | (33 | ) | (116 | ) | |||||||
Balance, end of period | $ | 323 | $ | 310 | $ | 323 | $ | 310 |
2015 | 2016 | ||||
Lender warrants to purchase common stock | 50,000 | 50,000 | |||
Stock options outstanding | 1,074,473 | 1,047,078 | |||
Unvested restricted stock units | — | 538,405 | |||
Possible future issuance under equity incentive plan | 380,460 | 167,624 | |||
Possible future issuance under employee stock purchase plan | 60,318 | 93,325 | |||
Total shares reserved | 1,565,251 | 1,896,432 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 (1) | 2016 | ||||||||||||
Other cost of revenue | $ | 21 | $ | 20 | $ | 53 | $ | 58 | |||||||
Sales and marketing | 184 | 182 | 526 | 549 | |||||||||||
Research and development | 303 | 329 | 765 | 1,001 | |||||||||||
General and administrative | 382 | 389 | 1,052 | 1,158 | |||||||||||
$ | 890 | $ | 920 | $ | 2,396 | $ | 2,766 |
(1) | Stock-based compensation expense included a favorable $0.2 million fair value adjustment related to stock option liability awards prior to reclassification to additional paid-in capital during the nine months ended September 30, 2015. |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2015 | 2016 | 2015 | 2016 | ||||
Risk-free interest rate | 1.57% - 1.76% | 1.16% - 1.33% | 1.57% - 1.87% | 1.16% - 1.53% | |||
Expected term (years) | 6.08 | 6.08 | 6.03 - 6.08 | 6.08 | |||
Expected volatility | 58% - 59% | 46% | 53% - 59% | 46% - 47% | |||
Dividend yield | —% | —% | —% | —% |
Number of Options | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term | Aggregate Intrinsic Value | |||||||||
(in years) | (in thousands) | |||||||||||
Outstanding balance at January 1, 2016 | 1,074,473 | $ | 30.69 | 8.39 | $ | 500 | ||||||
Granted | 115,360 | 8.55 | ||||||||||
Exercised | (29,875 | ) | 3.54 | |||||||||
Cancelled | (112,880 | ) | 31.39 | |||||||||
Outstanding balance at September 30, 2016 | 1,047,078 | $ | 28.95 | 7.86 | $ | 739 | ||||||
Exercisable at September 30, 2016 | 541,156 | $ | 30.27 | 7.07 | $ | 597 | ||||||
Vested and expected to vest at September 30, 2016 | 999,304 | $ | 29.36 | 7.81 | $ | 720 |
Three Months Ended September 30, 2016 | Nine Months Ended September 30, 2016 | ||||||
Other cost of revenue | $ | 3 | $ | 3 | |||
Sales and marketing | 10 | 10 | |||||
Research and development | 30 | 30 | |||||
General and administrative | 17 | 17 | |||||
$ | 60 | $ | 60 |
Number of Awards | Weighted- Average Grant Date Fair Value | |||||
Nonvested balance at January 1, 2016 | — | $ | — | |||
Granted | 540,420 | 8.87 | ||||
Vested | — | — | ||||
Forfeited | (2,015 | ) | 8.87 | |||
Nonvested balance at September 30, 2016 | 538,405 | $ | 8.87 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
Other cost of revenue | $ | 9 | $ | — | $ | 15 | $ | 4 | |||||||
Sales and marketing | 51 | 10 | 130 | 51 | |||||||||||
Research and development | 80 | 19 | 165 | 105 | |||||||||||
General and administrative | 20 | 5 | 50 | 22 | |||||||||||
$ | 160 | $ | 34 | $ | 360 | $ | 182 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2015 | 2016 | 2015 | 2016 | ||||
Risk-free interest rate | 0.10% | 0.41% | 0.10% | 0.27% - 0.41% | |||
Expected term (years) | 0.59 | 0.50 | 0.59 | 0.50 | |||
Expected volatility | 61% | 43% | 61% | 43% - 55% | |||
Dividend yield | —% | —% | —% | —% |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||
Lender warrants to purchase common stock | 50,000 | 50,000 | 50,000 | 50,000 | |||||||
2015 ESPP | 43,433 | 32,029 | 43,433 | 32,029 | |||||||
Restricted stock units | — | 538,405 | — | 538,405 | |||||||
Stock options | 1,052,425 | 1,047,078 | 1,052,425 | 1,047,078 |
• | Foot traffic measurement. Our location-based technology uses mobile activity, combined with offline store visits to measure success in terms of foot traffic of consumers for national brands. |
• | Trade promotion measurement. Our service provides store level sales lift measurement and neighborhood audience insights for in-store trade promotions. In-store trade promotion activities include in-store displays, endcaps and other promotional activities. |
• | Customer Catalyst. Our enhanced service offering linking permission-based customer relationship marketing data to specific household devices. |
• | PathPoint. Our wireless activity-sensing device offering which gathers privacy-friendly data on shoppers’ in-store activity. |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands) | |||||||||||||||
Revenue | $ | 35,969 | $ | 37,418 | $ | 99,135 | $ | 102,807 | |||||||
Traffic acquisition costs | 12,935 | 12,489 | 38,053 | 35,352 | |||||||||||
Other cost of revenue | 4,280 | 5,135 | 10,863 | 14,710 | |||||||||||
Gross profit | 18,754 | 19,794 | 50,219 | 52,745 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 12,883 | 11,182 | 38,521 | 37,736 | |||||||||||
Research and development | 6,127 | 7,083 | 16,206 | 20,671 | |||||||||||
General and administrative | 4,347 | 4,188 | 11,442 | 13,889 | |||||||||||
Total operating expenses | 23,357 | 22,453 | 66,169 | 72,296 | |||||||||||
Loss from operations | (4,603 | ) | (2,659 | ) | (15,950 | ) | (19,551 | ) | |||||||
Other expense (income): | |||||||||||||||
Interest expense | 190 | 261 | 1,060 | 761 | |||||||||||
Interest income | — | — | — | (3 | ) | ||||||||||
Amortization and write-off of debt discount | — | — | 1,108 | — | |||||||||||
Amortization and write-off of deferred financing costs | 8 | 11 | 189 | 39 | |||||||||||
Derivative fair value adjustment related to common stock warrants | — | — | (482 | ) | — | ||||||||||
Total other expense | 198 | 272 | 1,875 | 797 | |||||||||||
Loss before income taxes | (4,801 | ) | (2,931 | ) | (17,825 | ) | (20,348 | ) | |||||||
Provision for income taxes | — | — | — | — | |||||||||||
Net loss | $ | (4,801 | ) | $ | (2,931 | ) | $ | (17,825 | ) | $ | (20,348 | ) |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||
(as a percentage of revenue) | |||||||||||
Revenue | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||
Traffic acquisition costs | 36.0 | % | 33.4 | % | 38.4 | % | 34.4 | % | |||
Other cost of revenue | 11.9 | % | 13.7 | % | 11.0 | % | 14.3 | % | |||
Gross profit | 52.1 | % | 52.9 | % | 50.7 | % | 51.3 | % | |||
Operating expenses: | |||||||||||
Sales and marketing | 35.8 | % | 29.9 | % | 38.9 | % | 36.7 | % | |||
Research and development | 17.0 | % | 18.9 | % | 16.3 | % | 20.1 | % | |||
General and administrative | 12.1 | % | 11.2 | % | 11.5 | % | 13.5 | % | |||
Total operating expenses | 64.9 | % | 60.0 | % | 66.7 | % | 70.3 | % | |||
Loss from operations | (12.8 | )% | (7.1 | )% | (16.1 | )% | (19.0 | )% | |||
Other expense (income): | |||||||||||
Interest expense | 0.5 | % | 0.7 | % | 1.1 | % | 0.7 | % | |||
Interest income | — | % | — | % | — | % | — | % | |||
Amortization and write-off of debt discount | — | % | — | % | 1.1 | % | — | % | |||
Amortization and write-off of deferred financing costs | — | % | — | % | 0.2 | % | — | % | |||
Derivative fair value adjustment related to common stock warrants | — | % | — | % | (0.5 | )% | — | % | |||
Total other expense | 0.6 | % | 0.7 | % | 1.9 | % | 0.8 | % | |||
Loss before income taxes | (13.3 | )% | (7.8 | )% | (18.0 | )% | (19.8 | )% | |||
Provision for income taxes | — | % | — | % | — | % | — | % | |||
Net loss | (13.3 | )% | (7.8 | )% | (18.0 | )% | (19.8 | )% |
Three Months Ended September 30, | ||||||||||||||||||||
2015 | 2016 | |||||||||||||||||||
Percentage of Revenue | Percentage of Revenue | Period-to-Period Change | ||||||||||||||||||
Amount | Amount | Amount | Percentage | |||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||
Revenue | $ | 35,969 | 100.0 | % | $ | 37,418 | 100.0 | % | $ | 1,449 | 4.0 | % | ||||||||
Traffic acquisition costs | 12,935 | 36.0 | % | 12,489 | 33.4 | % | (446 | ) | (3.4 | )% | ||||||||||
Other cost of revenue | 4,280 | 11.9 | % | 5,135 | 13.7 | % | 855 | 20.0 | % | |||||||||||
Gross profit | 18,754 | 52.1 | % | 19,794 | 52.9 | % | 1,040 | 5.5 | % | |||||||||||
Operating expenses: | ||||||||||||||||||||
Sales and marketing | 12,883 | 35.8 | % | 11,182 | 29.9 | % | (1,701 | ) | (13.2 | )% | ||||||||||
Research and development | 6,127 | 17.0 | % | 7,083 | 18.9 | % | 956 | 15.6 | % | |||||||||||
General and administrative | 4,347 | 12.1 | % | 4,188 | 11.2 | % | (159 | ) | (3.7 | )% | ||||||||||
Total operating expenses | 23,357 | 64.9 | % | 22,453 | 60.0 | % | (904 | ) | (3.9 | )% | ||||||||||
Loss from operations | (4,603 | ) | (12.8 | )% | (2,659 | ) | (7.1 | )% | 1,944 | (42.2 | )% | |||||||||
Other expense (income): | ||||||||||||||||||||
Interest expense | 190 | 0.5 | % | 261 | 0.7 | % | 71 | 37.4 | % | |||||||||||
Amortization and write-off of deferred financing costs | 8 | — | % | 11 | — | % | 3 | 37.5 | % | |||||||||||
Total other expense | 198 | 0.6 | % | 272 | 0.7 | % | 74 | 37.4 | % | |||||||||||
Loss before income taxes | (4,801 | ) | (13.3 | )% | (2,931 | ) | (7.8 | )% | 1,870 | (39.0 | )% | |||||||||
Provision for income taxes | — | — | % | — | — | % | — | — | % | |||||||||||
Net loss | $ | (4,801 | ) | (13.3 | )% | $ | (2,931 | ) | (7.8 | )% | $ | 1,870 | (39.0 | )% |
Nine Months Ended September 30, | ||||||||||||||||||||
2015 | 2016 | |||||||||||||||||||
Percentage of Revenue | Percentage of Revenue | Period-to-Period Change | ||||||||||||||||||
Amount | Amount | Amount | Percentage | |||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||
Revenue | $ | 99,135 | 100.0 | % | $ | 102,807 | 100.0 | % | $ | 3,672 | 3.7 | % | ||||||||
Traffic acquisition costs | 38,053 | 38.4 | % | 35,352 | 34.4 | % | (2,701 | ) | (7.1 | )% | ||||||||||
Other cost of revenue | 10,863 | 11.0 | % | 14,710 | 14.3 | % | 3,847 | 35.4 | % | |||||||||||
Gross profit | 50,219 | 50.7 | % | 52,745 | 51.3 | % | 2,526 | 5.0 | % | |||||||||||
Operating expenses: | ||||||||||||||||||||
Sales and marketing | 38,521 | 38.9 | % | 37,736 | 36.7 | % | (785 | ) | (2.0 | )% | ||||||||||
Research and development | 16,206 | 16.3 | % | 20,671 | 20.1 | % | 4,465 | 27.6 | % | |||||||||||
General and administrative | 11,442 | 11.5 | % | 13,889 | 13.5 | % | 2,447 | 21.4 | % | |||||||||||
Total operating expenses | 66,169 | 66.7 | % | 72,296 | 70.3 | % | 6,127 | 9.3 | % | |||||||||||
Loss from operations | (15,950 | ) | (16.1 | )% | (19,551 | ) | (19.0 | )% | (3,601 | ) | 22.6 | % | ||||||||
Other expense (income): | ||||||||||||||||||||
Interest expense | 1,060 | 1.1 | % | 761 | 0.7 | % | (299 | ) | (28.2 | )% | ||||||||||
Interest income | — | — | % | (3 | ) | — | % | (3 | ) | * | ||||||||||
Amortization and write-off of debt discount | 1,108 | 1.1 | % | — | — | % | (1,108 | ) | (100.0 | )% | ||||||||||
Amortization and write-off of deferred financing costs | 189 | 0.2 | % | 39 | — | % | (150 | ) | (79.4 | )% | ||||||||||
Derivative fair value adjustment related to common stock warrants | (482 | ) | (0.5 | )% | — | — | % | 482 | (100.0 | )% | ||||||||||
Total other expense | 1,875 | 1.9 | % | 797 | 0.8 | % | (1,078 | ) | (57.5 | )% | ||||||||||
Loss before income taxes | (17,825 | ) | (18.0 | )% | (20,348 | ) | (19.8 | )% | (2,523 | ) | 14.2 | % | ||||||||
Provision for income taxes | — | — | % | — | — | % | — | — | % | |||||||||||
Net loss | $ | (17,825 | ) | (18.0 | )% | $ | (20,348 | ) | (19.8 | )% | $ | (2,523 | ) | 14.2 | % |
* | Not meaningful. |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands, except number of enterprise customers) | |||||||||||||||
Revenue | $ | 35,969 | $ | 37,418 | $ | 99,135 | $ | 102,807 | |||||||
Revenue ex-TAC | $ | 23,034 | $ | 24,929 | $ | 61,082 | $ | 67,455 | |||||||
Adjusted EBITDA | $ | (1,925 | ) | $ | 880 | $ | (8,924 | ) | $ | (9,406 | ) | ||||
Number of enterprise customers | 670 | 766 | 670 | 766 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands) | |||||||||||||||
Revenue | $ | 35,969 | $ | 37,418 | $ | 99,135 | $ | 102,807 | |||||||
Less: traffic acquisition costs | (12,935 | ) | (12,489 | ) | (38,053 | ) | (35,352 | ) | |||||||
Revenue ex-TAC | $ | 23,034 | $ | 24,929 | $ | 61,082 | $ | 67,455 |
• | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; |
• | Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; |
• | Adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; |
• | Adjusted EBITDA does not reflect interest or tax payments that may represent a reduction in cash available to us; |
• | our definition of Adjusted EBITDA for use as an operating result measure, described above, differs from the Adjusted EBITDA definition used by our lender to calculate our amended loan and security agreement quarterly covenant; and |
• | other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure. |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands) | |||||||||||||||
Net loss | $ | (4,801 | ) | $ | (2,931 | ) | $ | (17,825 | ) | $ | (20,348 | ) | |||
Adjustments: | |||||||||||||||
Interest expense | 190 | 261 | 1,060 | 761 | |||||||||||
Interest income | — | — | — | (3 | ) | ||||||||||
Amortization and write-off of debt discount | — | — | 1,108 | — | |||||||||||
Amortization and write-off of deferred financing costs | 8 | 11 | 189 | 39 | |||||||||||
Provision for income taxes | — | — | — | — | |||||||||||
Depreciation and amortization | 1,628 | 2,525 | 4,270 | 7,137 | |||||||||||
Stock-based compensation | 1,050 | 1,014 | 2,756 | 3,008 | |||||||||||
Change in fair value of warrants | — | — | (482 | ) | — | ||||||||||
Adjusted EBITDA | $ | (1,925 | ) | $ | 880 | $ | (8,924 | ) | $ | (9,406 | ) |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands) | |||||||||||||||
Other cost of revenue | $ | 1,144 | $ | 1,778 | $ | 2,942 | $ | 5,097 | |||||||
Sales and marketing | 111 | 123 | 300 | 356 | |||||||||||
Research and development | 348 | 592 | 966 | 1,591 | |||||||||||
General and administrative | 25 | 32 | 62 | 93 | |||||||||||
Total depreciation and amortization | $ | 1,628 | $ | 2,525 | $ | 4,270 | $ | 7,137 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2015 | 2016 | 2015 | 2016 | ||||||||||||
(in thousands) | |||||||||||||||
Other cost of revenue | $ | 30 | $ | 23 | $ | 68 | $ | 65 | |||||||
Sales and marketing | 235 | 202 | 656 | 610 | |||||||||||
Research and development | 383 | 378 | 930 | 1,136 | |||||||||||
General and administrative | 402 | 411 | 1,102 | 1,197 | |||||||||||
Total stock-based compensation | $ | 1,050 | $ | 1,014 | $ | 2,756 | $ | 3,008 |
2016 | |||
Third Amended New Revolving Line of Credit | $ | 26,125 | |
Total | $ | 26,125 |
As of and for the Nine Months Ended September 30, | |||||||
2015 | 2016 | ||||||
Cash and cash equivalents | $ | 48,864 | $ | 24,122 | |||
Accounts receivable, net | $ | 34,262 | $ | 35,147 | |||
Working capital | $ | 36,170 | $ | 15,644 | |||
Cash (used in) provided by: | |||||||
Operating activities | $ | (4,419 | ) | $ | (6,928 | ) | |
Investing activities | $ | (10,227 | ) | $ | (5,074 | ) | |
Financing activities | $ | 50,566 | $ | (4,971 | ) |
Payment Due by Period | ||||||||||||||||||||
Less than 1 Year | More than 5 Years | |||||||||||||||||||
Contractual Obligations(1) | Total | 1 - 3 Years | 3 - 5 Years | |||||||||||||||||
(in thousands) | ||||||||||||||||||||
Debt: | ||||||||||||||||||||
Third Amended New Revolving Line of Credit | $ | 26,125 | $ | — | $ | 26,125 | $ | — | $ | — | ||||||||||
Interest payments | 1,308 | 1,045 | 263 | — | — | |||||||||||||||
Operating lease obligations | 12,983 | 2,877 | 5,153 | 2,865 | 2,088 | |||||||||||||||
Purchase commitments | 3,341 | 2,970 | 371 | — | — | |||||||||||||||
Total contractual obligations | $ | 43,757 | $ | 6,892 | $ | 31,912 | $ | 2,865 | $ | 2,088 |
(1) | This principal payment projection assumes no changes in the borrowing base calculation and that principal will be due at maturity. Interest payment projections on our loan and security agreement assume that we will not incur a material change in our outstanding borrowings, in the current interest rate, or in the maturity date of December 31, 2017. |
• | build a reputation for a superior solution and create trust and long-term relationships with customers and advertising agencies; |
• | distinguish ourselves from competitors in our industry; |
• | offer a competitive technology platform; |
• | develop additional product and service offerings that meet our customers’ evolving needs; |
• | achieve our operating plans; |
• | comply with the covenants within our loan and security agreement; |
• | maintain and expand our relationships with the real-time bidding, or RTB, exchanges and other programmatic or direct media sources through which we execute our customers’ digital marketing campaigns; |
• | respond to evolving industry standards and government regulations that impact our business, particularly in the areas of data collection and consumer privacy; |
• | prevent or otherwise mitigate failures or breaches of security or privacy; |
• | expand our business internationally; and |
• | attract, hire, integrate and retain qualified and motivated employees. |
• | dispose of or sell assets; |
• | make material changes in our business or management; |
• | consolidate or merge with or acquire other entities; |
• | incur additional indebtedness; |
• | incur liens on our assets; |
• | pay dividends or make distributions on our capital stock; |
• | make certain investments; |
• | enter into transactions with our affiliates; and |
• | make any payment in respect of any subordinated indebtedness. |
• | changes in our customers’ advertising budget allocations, agency affiliations or marketing strategies; |
• | changes in the economic prospects of our customers or the economy generally, which could alter current or prospective customers’ spending priorities, or increase the time or costs required to complete sales; |
• | changes in demand for and pricing of our MaxPoint Intelligence Platform; |
• | the impact of seasonality on our customers’ businesses and budgets for digital marketing campaigns, particularly our consumer product and retail customers; |
• | the impact of macroeconomic, market and political factors and trends, including in light of "Brexit," and other recent political developments; |
• | unpredictable sales cycles; |
• | changes in our pricing policies, or the pricing policies of our competitors, RTB exchanges or other third-party service providers; |
• | the addition or loss of customers; |
• | the growth or reduction of business with current customers or advertising agencies that act on their behalf; |
• | changes and uncertainty in the regulatory environment for us or our customers; |
• | changes in the availability of media inventory through RTB exchanges; |
• | the introduction of new technologies, products or service offerings by us or our competitors; |
• | changes in our operating expenses and capital expenditures; and |
• | costs related to acquisitions of people, businesses or technologies. |
• | digital advertising services offered by other companies, including those owned by traditional advertising and direct marketing companies; |
• | ERP vendors such as Adobe, Oracle, Salesforce.com and IBM; |
• | companies that offer demand-side platforms that allow customers to purchase inventory directly from RTB exchanges or other third parties; |
• | advertising networks and advertising agencies, including agency trading desks; |
• | digital services offered through large online platforms, such as Yahoo! Inc., Google Inc. and Facebook, Inc.; |
• | in-house solutions used by our customers; |
• | companies providing online search advertising, for which we do not offer a solution; and |
• | technology companies providing online marketing platforms focused on local businesses. |
• | announcements of new offerings, products, services or technologies, commercial relationships, acquisitions or other events by us or our competitors; |
• | price and volume fluctuations in the overall stock market from time to time; |
• | significant volatility in the market price and trading volume of technology companies in general and of companies in the digital advertising industry in particular; |
• | competitive factors; |
• | fluctuations in the trading volume of our shares or the size of our public float; |
• | actual or anticipated changes or fluctuations in our results of operations or key metrics; |
• | whether our results of operations or key metrics meet our forecasts or the expectations of securities analysts or investors or those expectations change; |
• | litigation involving us, our industry, or both; |
• | regulatory developments in the United States, foreign countries, or both; |
• | the impact of macroeconomic, market and political factors and trends, including in light of "Brexit," and other recent political developments; |
• | major catastrophic events; |
• | sales of large blocks of our common stock; |
• | departures of key employees; or |
• | an adverse impact on the company from any of the other risks cited in this report. |
• | a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our board of directors; |
• | the ability of our board of directors to issue shares of convertible preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror; |
• | the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors; |
• | a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; |
• | the requirement that a special meeting of stockholders may be called only by a majority vote of our entire board of directors, the chairman of our board of directors or our chief executive officer, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; |
• | the requirement for the affirmative vote of holders of at least 662/3% of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, to amend the provisions of our amended and restated certificate of incorporation relating to the management of our business or our amended and restated bylaws, which may inhibit the ability of an acquiror to effect such amendments to facilitate an unsolicited takeover attempt; and |
• | advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror’s own slate of directors or otherwise attempting to obtain control of us. |
MAXPOINT INTERACTIVE, INC. | ||||
Date: November 10, 2016 | By: | / s / Joseph Epperson | ||
Name: | Joseph Epperson | |||
Title: | President, Chief Executive Officer and Chairman | |||
(Principal Executive Officer) | ||||
By: | / s / Brad Schomber | |||
Name: | Brad Schomber | |||
Title: | Chief Financial Officer | |||
(Principal Financial and Accounting Officer) |
Incorporated by Reference | ||||||||||
Exhibit No. | Description | Form | File No. | Exhibit | Filing Date | |||||
3.1 | Amended and Restated Certificate of Incorporation of MaxPoint Interactive, Inc. | 8-K | 001-36864 | 3.1 | 3/12/2015 | |||||
3.2 | Amended and Restated Bylaws of MaxPoint Interactive, Inc. | 8-K | 001-36864 | 3.2 | 3/12/2015 | |||||
3.3 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of MaxPoint Interactive, Inc. | 8-K | 001-36864 | 3.1 | 4/25/2016 | |||||
10.1 | Third Amendment to Loan and Security Agreement, dated September 30, 2016, between the Registrant and Silicon Valley Bank. | 8-K | 001-36864 | 10.1 | 10/5/2016 | |||||
10.2 | Forms of restricted stock unit agreements under the 2015 Equity Incentive Plan | |||||||||
10.3 | CSOP under the 2015 Equity Incentive Plan and forms of agreements thereunder | |||||||||
10.4 | Form of UK stock option agreement under the 2015 Equity Incentive Plan | |||||||||
31.1 | Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||||||
31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||||||
32.1† | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||||||
32.2† | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||||||
101.INS | XBRL Instance Document. | |||||||||
101.SCH | XBRL Taxonomy Extension Schema Document. | |||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. |
† | The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of MaxPoint Interactive, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, regardless of any general incorporation language contained in any filing. |
Name of Recipient: | «Name» |
Total Number of Stock Units Granted: | «TotalUnits» |
Date of Grant: | «DateGrant» |
Vesting Commencement Date: | «VestDay» |
Vesting Schedule: | «To be completed» |
RECIPIENT | MAXPOINT INTERACTIVE, INC. | |||
By: | ||||
Title: |
Grant of Units | Subject to all of the terms and conditions set forth in the Notice of Stock Unit Award, this Stock Unit Agreement (the “Agreement”) and the Plan, the Company has granted to you the number of stock units set forth in the Notice of Stock Unit Award. All capitalized terms used in this Agreement shall have the meanings assigned to them in this Agreement, the Notice of Stock Unit Award or the Plan. |
Payment for Units | No payment is required for the stock units that you are receiving. |
Vesting | The stock units vest in accordance with the vesting schedule set forth in the Notice of Stock Unit Award. No additional stock units will vest after your Service has terminated for any reason. |
Forfeiture | If your Service terminates for any reason, then your stock units will be forfeited to the extent that they have not vested before the termination date and do not vest as a result of the termination of your Service. This means that any stock units that have not vested under this Agreement will be cancelled immediately. You receive no payment for stock units that are forfeited. The Company determines when your Service terminates for all purposes of your stock units. |
Leaves of Absence and Part-Time Work | For purposes of this award, your Service does not terminate when you go on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of Service is required by applicable law, the Company’s leave of absence policy, or the terms of your leave. However, your Service terminates when the approved leave ends, unless you immediately return to active work. |
If you go on a leave of absence, then the vesting schedule specified in the Notice of Stock Unit Award may be adjusted in accordance with the Company’s leave of absence policy or the terms of your leave. If you commence working on a part-time basis, the Company may adjust the vesting schedule so that the rate of vesting is commensurate with your reduced work schedule. |
Settlement of Units | Each stock unit will be settled when it vests (unless you and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion); provided that in all events the stock unit will be settled within the applicable “short term deferral” period as prescribed under Code Section 409A. At the time of settlement, you will be issued one share of the Company’s common stock for each vested stock unit; provided that the Company has the right to retain (not deliver) that number of shares issued upon settlement required to satisfy applicable tax withholding obligations on the terms described below. No fractional shares will be issued upon settlement. In order for the Company to issue any shares to you upon settlement of your vested stock units, you will need to have a trading brokerage account with a broker designated by the Company. If before the initial settlement date of your stock units you have not completed all steps necessary to open an account at the designated broker, then the Company will need to open one on your behalf. You agree to execute such documents as the Company determines necessary and appropriate, including if necessary a power of attorney empowering the Company, to open an account on your behalf for these purposes. |
Section 409A | Unless you and the Company have agreed to a deferred settlement date (pursuant to procedures that the Company may prescribe at its discretion), settlement of these restricted stock units is intended to be exempt from the application of Code Section 409A pursuant to Treasury Regulation 1.409A-1(b)(4) and shall be administered and interpreted in a manner that complies with such exception. Notwithstanding the foregoing, if the Company determines that you are a “specified employee,” as defined in the regulations under Code Section 409A at the time of your “separation from service,” as defined in Treasury Regulation Section 1.409A-1(h) and it is determined that settlement of these stock units is not exempt from Code Section 409A, then this paragraph will apply. If this paragraph applies, and the event triggering settlement is your “separation from service,” then any stock units that otherwise would have been settled during the first six months following your “separation from service” will instead be settled on the first business day following the earlier of (i) the six-month anniversary of your separation from service or (ii) your death. Each installment of stock units that vests is hereby designated as a separate payment for purposes of Code Section 409A. |
Nature of Units | Your stock units are mere bookkeeping entries. They represent only the Company’s unfunded and unsecured promise to issue shares of common stock (or distribute cash) on a future date. As a holder of stock units, you have no rights other than the rights of a general creditor of the Company. |
No Voting Rights or Dividends | Your stock units carry neither voting rights nor rights to cash dividends. You have no rights as a stockholder of the Company unless and until your stock units are settled by issuing shares of the Company’s common stock. |
Units Nontransferable | You may not sell, transfer, assign, pledge or otherwise dispose of any stock units. For instance, you may not use your stock units as security for a loan. |
Beneficiary Designation | You may dispose of your stock units in a written beneficiary designation. A beneficiary designation must be filed with the Company on the proper form. It will be recognized only if it has been received at the Company’s headquarters before your death. If you file no beneficiary designation or if none of your designated beneficiaries survives you, then your estate will receive any vested stock units that you hold at the time of your death. |
Withholding Taxes | No stock certificates (or their electronic equivalent) or cash will be distributed to you, and no portion of stock units will be settled, unless you have made arrangements satisfactory to the Company for the payment of any withholding taxes that are due as a result of the vesting or settlement of the stock units. If you fail to make satisfactory arrangements with respect to such tax withholding obligations within two-and-one-half months following the end of the calendar year in which the applicable vesting date occurs, then the applicable portion of the stock units shall be forfeited. Pursuant to such procedures as the Company may specify from time to time, tax withholding obligations will be satisfied by the Company’s withholding a number of shares of common stock otherwise issuable upon settlement of the stock units, or portion thereof, having an aggregate fair market value sufficient to satisfy the required federal, state and local tax withholding obligations attributable to the vesting stock units, but not greater than the withholding obligations determined applicable by the Company in its discretion. In the sole discretion of the Committee, the Company may instead require or permit that any applicable withholding obligations be satisfied by any other legal method permitted under the Plan. |
Restrictions on Resale | You agree not to sell any shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify. |
Retention Rights | Your award or this Agreement does not give you the right to be retained by the Company, a Parent, Subsidiary, or an Affiliate in any capacity. The Company and its Parents, Subsidiaries, and Affiliates reserve the right to terminate your Service at any time, with or without cause. |
Adjustments | In the event of a stock split, a stock dividend or a similar change in Company stock, the number of your stock units will be adjusted accordingly, as the Company may determine pursuant to the Plan. |
Effect of Significant Corporate Transactions | If the Company is a party to a merger, consolidation, or certain change in control transactions, then your stock units will be subject to the applicable provisions of Article 9 of the Plan, provided that any action taken must either (a) preserve the exemption of your stock units from Code Section 409A or (b) comply with Code Section 409A. |
Recoupment Policy | This award, and the shares acquired upon settlement of this award, shall be subject to any Company recoupment or clawback policy in effect from time to time. |
Applicable Law | This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to its choice-of-law provisions). |
The Plan and Other Agreements | The text of the Plan is incorporated in this Agreement by reference. The Plan, this Agreement and the Notice of Stock Unit Award constitute the entire understanding between you and the Company regarding this award. Any prior agreements, commitments or negotiations concerning this award are superseded. This Agreement may be amended only by another written agreement between the parties. |
Name of Recipient: | «Name» |
Total Number of Stock Units Granted: | «TotalUnits» |
Date of Grant: | «DateGrant» |
Vesting Commencement Date: | «VestDay» |
Vesting Schedule: | «To be completed» |
RECIPIENT | MAXPOINT INTERACTIVE, INC. | |||
By: | ||||
Title: |
Grant of Units | Subject to all of the terms and conditions set forth in the Notice of Stock Unit Award, this Stock Unit Agreement (the “Agreement”) and the Plan, the Company has granted to you the number of stock units set forth in the Notice of Stock Unit Award. All capitalized terms used in this Agreement shall have the meanings assigned to them in this Agreement, the Notice of Stock Unit Award or the Plan. |
Payment for Units | No payment is required for the stock units that you are receiving. |
Vesting | The stock units vest in accordance with the vesting schedule set forth in the Notice of Stock Unit Award. No additional stock units will vest after your Service has terminated for any reason. |
Forfeiture | If your Service terminates for any reason, then your stock units will be forfeited to the extent that they have not vested before the termination date and do not vest as a result of the termination of your Service. This means that any stock units that have not vested under this Agreement will be cancelled immediately. You receive no payment for stock units that are forfeited. The Company determines when your Service terminates for all purposes of your stock units. |
Leaves of Absence and Part-Time Work | For purposes of this award, your Service does not terminate when you go on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of Service is required by applicable law, the Company’s leave of absence policy, or the terms of your leave. However, your Service terminates when the approved leave ends, unless you immediately return to active work. |
If you go on a leave of absence, then the vesting schedule specified in the Notice of Stock Unit Award may be adjusted in accordance with the Company’s leave of absence policy or the terms of your leave. If you commence working on a part-time basis, the Company may adjust the vesting schedule so that the rate of vesting is commensurate with your reduced work schedule. |
Settlement of Units | Each stock unit will be settled when it vests (unless you and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion); provided that in all events the stock unit will be settled within the applicable “short term deferral” period as prescribed under Code Section 409A. At the time of settlement, you will be issued one share of the Company’s common stock for each vested stock unit; provided that the Company has the right to retain (not deliver) that number of shares issued upon settlement required to satisfy applicable tax withholding obligations on the terms described below. No fractional shares will be issued upon settlement. In order for the Company to issue any shares to you upon settlement of your vested stock units, you will need to have a trading brokerage account with a broker designated by the Company. If before the initial settlement date of your stock units you have not completed all steps necessary to open an account at the designated broker, then the Company will need to open one on your behalf. You agree to execute such documents as the Company determines necessary and appropriate, including if necessary a power of attorney empowering the Company, to open an account on your behalf for these purposes. |
Data Protection | For the purposes of this section, personal data means any information which relates to an identified or identifiable living individual ("Personal Data"). In order to administer the Plan, you consent to the collection, holding, processing and transfer of your Personal Data by the Company for all purposes connected with the operation of the Plan. This includes transferring your Personal Data to a country, territory or state outside the European Economic Area that may not provide the same statutory protection for the information as countries within the European Economic Area. The purposes of the Plan referred to above include, but are not limited to: • holding and maintaining details of your Stock Unit Award and stock units; • transferring your Personal Data to the Company's registrars or brokers or any administrators of the Plan; and • transferring your Personal Data to a bona fide prospective buyer of the Company or business unit (and/or their advisers). |
Tax Matters | Where a liability to pay, or account for, income tax, primary class 1 (employee) national insurance contributions and/or, unless the Company directs otherwise and to the extent that it can be lawfully recovered from you, any secondary class 1 (employer) national insurance contributions arises (or appears to the reasonable satisfaction of the Company to arise) under the law of the United Kingdom upon settlement of, release, assignment, surrender, disposal, or the receipt of any benefit in connection with, the stock units or a portion thereof or any shares of the Company's common stock that has been acquired by you as a result of your stock units (including any failure to make good such an amount within the time limit specified in section 222 of the UK Income Tax (Earnings and Pensions) Act 2003 ("ITEPA")), you agree that: • any such liability may be recovered from you by the Company through the methods set out in the "Withholding" and "Settlement of Units" sections of this Agreement and paid to the relevant tax authority within the appropriate tax deadlines applicable under UK law; and • where requested to do so by the Company you agree to enter into a joint election under section 431 of ITEPA in respect of all or any of the shares of the Company's common stock that has been issued to you upon settlement of your vested stock units within 14 days of being issued such shares to disapply in full the UK restricted securities legislation in Chapter 2 of Part 7 of ITEPA. |
Nature of Units | Your stock units are mere bookkeeping entries. They represent only the Company’s unfunded and unsecured promise to issue shares of common stock (or distribute cash) on a future date. As a holder of stock units, you have no rights other than the rights of a general creditor of the Company. |
No Voting Rights or Dividends | Your stock units carry neither voting rights nor rights to cash dividends. You have no rights as a stockholder of the Company unless and until your stock units are settled by issuing shares of the Company’s common stock. |
Units Nontransferable | You may not sell, transfer, assign, pledge or otherwise dispose of any stock units. For instance, you may not use your stock units as security for a loan. |
Beneficiary Designation | You may dispose of your stock units in a written beneficiary designation. A beneficiary designation must be filed with the Company on the proper form. It will be recognized only if it has been received at the Company’s headquarters before your death. If you file no beneficiary designation or if none of your designated beneficiaries survives you, then your estate will receive any vested stock units that you hold at the time of your death. |
Withholding Taxes | No stock certificates (or their electronic equivalent) or cash will be distributed to you, and no portion of stock units will be settled, unless you have made arrangements satisfactory to the Company for the payment of any withholding taxes that are due as a result of the vesting or settlement of the stock units. If you fail to make satisfactory arrangements with respect to such tax withholding obligations within two-and-one-half months following the end of the calendar year in which the applicable vesting date occurs, then the applicable portion of the stock units shall be forfeited. Pursuant to such procedures as the Company may specify from time to time, tax withholding obligations will be satisfied by the Company’s withholding a number of shares of common stock otherwise issuable upon settlement of the stock units, or portion thereof, having an aggregate fair market value sufficient to satisfy the required federal, state and local tax withholding obligations attributable to the vesting stock units, but not greater than the withholding obligations determined applicable by the Company in its discretion. In the sole discretion of the Committee, the Company may instead require or permit that any applicable withholding obligations be satisfied by any other legal method permitted under the Plan. |
Restrictions on Resale | You agree not to sell any shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify. |
Retention Rights | Your award or this Agreement does not give you the right to be retained by the Company, a Parent, Subsidiary, or an Affiliate in any capacity. The Company and its Parents, Subsidiaries, and Affiliates reserve the right to terminate your Service at any time, with or without cause. |
Adjustments | In the event of a stock split, a stock dividend or a similar change in Company stock, the number of your stock units will be adjusted accordingly, as the Company may determine pursuant to the Plan. |
Effect of Significant Corporate Transactions | If the Company is a party to a merger, consolidation, or certain change in control transactions, then your stock units will be subject to the applicable provisions of Article 9 of the Plan, provided that any action taken must either (a) preserve the exemption of your stock units from Code Section 409A or (b) comply with Code Section 409A. |
Recoupment Policy | This award, and the shares acquired upon settlement of this award, shall be subject to any Company recoupment or clawback policy in effect from time to time. |
Applicable Law | This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to its choice-of-law provisions). |
The Plan and Other Agreements | The text of the Plan is incorporated in this Agreement by reference. The Plan, this Agreement and the Notice of Stock Unit Award constitute the entire understanding between you and the Company regarding this award. Any prior agreements, commitments or negotiations concerning this award are superseded. This Agreement may be amended only by another written agreement between the parties. |
1 | INTERPRETATION |
1.1 | The following definitions and rules of interpretation apply in the Plan. |
(a) | any employee of a Group Company who is tax resident in the UK; and |
(b) | any director of a Group Company who tax resident in the UK and who is required to devote at least 25 hours per week (excluding meal breaks) to their duties; |
(i) | has a Material Interest (either on their own or together with one or more of their Associates), or has had such an interest in the last 12 months; and |
(ii) | has an Associate or Associates that has or (taken together) have a Material Interest, or had such an interest in the last 12 months. |
(a) | if Shares are to be newly issued to satisfy the exercise of the Option, may not be less than the nominal value of a Share; and |
(b) | may not be less than the Market Value of a Share on the Grant Date (or such earlier date as determined in accordance with paragraph 22 of Schedule 4). |
(a) | Options; and |
(b) | options granted under any other Schedule 4 CSOP that has been established by the Company or any of its Associated Companies (as defined in paragraph 35 of Schedule 4). |
(a) | must be met before an Option can be exercised at all; and/or |
(b) | provides that the extent to which an Option becomes capable of exercise shall be determined by reference to performance over a certain period measured against specified targets. |
(a) | the Option, including its exercise, assignment or surrender for consideration, or the receipt of any benefit in connection with it; |
(b) | any Shares (or other securities or assets): |
(i) | earmarked or held to satisfy the Option; |
(ii) | acquired on exercise of the Option; |
(iii) | acquired as a result of holding the Option; |
(iv) | acquired in consideration of the assignment or surrender of the Option; |
(c) | any securities (or other assets) acquired or earmarked as a result of holding Shares (or other securities or assets) mentioned in (b); |
(d) | entering into an election under section 430 or 431 of ITEPA 2003; or |
(e) | any amount due under PAYE in respect of securities or assets within (a) to (d) above, including any failure by the Option Holder to make good such an amount within the time limit specified in section 222 of ITEPA 2003. |
1.2 | Rule headings do not form part of the relevant rule and do not affect the interpretation of the Plan. |
1.3 | Unless the context otherwise requires: |
(a) | words in the singular shall include the plural and in the plural shall include the singular; and |
(b) | a reference to one gender shall include a reference to the other genders. |
1.4 | A reference to a statute or statutory provision is a reference to it as amended, extended or re-enacted from time to time and includes all subordinate legislation made from time to time under that statute or statutory provision. |
1.5 | Writing or written includes fax and email. |
1.6 | A reference to the Plan or to any other agreement or document referred to in the Plan is a reference to the Plan or such other agreement or document as validly varied or novated and a reference to a rule is to the rules of the Plan. |
2 | GRANT OF OPTIONS |
2.1 | Subject to the rules of the Plan, the Company may grant Options to any Eligible Employee it chooses at any time. |
2.2 | Options may be granted except where prohibited by: |
(a) | law; |
(b) | regulation with the force of law; or |
(c) | rule of an investment exchange on which Shares are listed or traded, or any other non-statutory rule that binds the Company or with which the Board has resolved to comply. |
2.3 | An Option shall be granted by the Company executing an Option Certificate as a deed in a form approved by the Board. Each Option Certificate shall be sent to the relevant Option Holder and shall specify (amongst other things): |
(a) | the Grant Date; |
(b) | the number and class of the Shares over which the Option is granted; |
(c) | the Exercise Price; |
(d) | the Normal Vesting Date; |
(e) | the date when the Option will lapse (being no later than the tenth anniversary of the Grant Date) subject to earlier lapse or exercise in accordance with these rules. |
(f) | any Performance Conditions, and the method by which the Performance Conditions may be varied or waived; |
(g) | a statement that: |
(i) | the Option is subject to these rules, Schedule 4 and any other legislation applying to Schedule 4 CSOPs which shall prevail over any conflicting statement as to the Option's terms; |
(ii) | whether or not the shares are subject to any Relevant Restrictions and, if so, the nature of the Relevant Restrictions; and |
(iii) | the circumstances in which the Option will lapse other than by effluxion of time; |
(h) | the Exercise Price; |
(i) | the number and description of the Shares under the Option; |
(j) | any restrictions attaching to the Shares; |
(k) | the time the Option can be exercised; and |
(l) | the circumstances in which the Option will lapse and any exercise conditions. |
2.4 | No amount shall be paid for the grant of an Option. |
3 | PERFORMANCE CONDITIONS |
3.1 | On the Grant Date of any Option, the Company: |
(a) | may specify one or more Performance Conditions for the Option; and |
(b) | may specify, for any Performance Condition: |
(i) | any restrictions that will apply to variation or waiver of that Performance Condition under rule 3.4; or |
(ii) | that there may be no such variation or waiver. |
3.2 | A Performance Condition may be specified to apply only to part of an Option. |
3.3 | Any Performance Condition shall be an objective measure of the performance of: |
(a) | the Company; |
(b) | the Option Holder; or |
(c) | a business unit of which the Option Holder is a part. |
3.4 | Subject to any restrictions on variation or waiver specified by the Company under rule 3.1(b), the Board may vary or waive any Performance Condition if events occur that cause: |
(a) | an Option to become exercisable before the end of the period over which the original Performance Condition was to be assessed, if the original Performance Condition cannot reasonably be applied to the shortened time period; or |
(b) | the Board to decide the Performance Condition is no longer an appropriate measure of performance. |
3.5 | If the Board varies the Performance Condition under rule 3.4 the varied Performance Condition must be (in the reasonable opinion of the Board): |
(a) | no more difficult to satisfy than the original Performance Condition was at the Grant Date; and |
(b) | not materially easier to satisfy than the original Performance Condition was at the Grant Date, unless the variation of the Performance Condition has been approved in advance by the Company as required under the governing law under which the Company operates. |
3.6 | The Board shall determine whether, and to what extent, Performance Conditions have been satisfied and certify this to the Option Holder in writing. |
3.7 | If an Option is subject to any Performance Condition, the Board shall notify the Option Holder within a reasonable time after the Board becomes aware of the relevant information: |
(a) | when that Performance Condition has become incapable of being satisfied, in whole or in part; and |
(b) | of any waiver or variation of that Performance Condition under rule 3.4. |
4 | OVERALL LIMITS ON GRANTS |
5 | INDIVIDUAL LIMITS ON GRANTS |
6 | TRANSFER OF OPTIONS |
6.1 | Options may not be transferred or assigned or have any charge or other security interest created over them save where rule 6.3 applies. |
6.2 | Where rule 6.1 is engaged and rule 6.3 does not apply, the Option shall lapse immediately in accordance with Rule 7. |
6.3 | Rule 6.1 does not apply where an Option is transmitted to an Option Holder's personal representatives on the death of the Option Holder. |
7 | LAPSE AND SUSPENSION OF OPTIONS |
7.1 | Except where rule 10.6 applies, an Option (or part of an Option as applicable) shall lapse on the earliest of: |
(a) | Rule 6.2 applying; |
(b) | any Performance Condition becomes incapable of being met, or is not met on the date on which the Board measures the Performance Condition; |
(c) | the lapse date specified in the Option Certificate; |
(d) | the expiry of any time limit for the exercise of an Option specified in rule 10; |
(e) | subject to the Board's ability to permit exercise of the Option rule 10.11, 90 days following the Option Holder ceasing employment with a Group Company; |
(f) | if any part of rule 14 applies, the time specified for the lapse of the Option under the relevant part of rule 14; or |
(g) | when the Option Holder becomes bankrupt under Part IX of the Insolvency Act 1986, or applies for an interim order under Part VIII of the Insolvency Act 1986, or proposes or makes a voluntary arrangement under Part VIII of the Insolvency Act 1986, or takes similar steps, or is similarly affected, under laws of any jurisdiction that correspond to those provisions of the Insolvency Act. |
7.2 | Where rule 10.6 applies, the Option lapses on the first anniversary of the Option Holder's death. |
8 | EXERCISE OF OPTIONS: GENERAL |
8.1 | An Option Holder may exercise an Option from the earliest of: |
(a) | the Normal Vesting Date; |
(b) | the time it becomes exercisable under rule 10 (Termination of Employment); and |
(c) | the time it becomes exercisable under rule 14 (Takeovers and Liquidations). |
8.2 | An Option Holder may only exercise an Option to the extent that the relevant Performance Condition is achieved (unless waived under rule 3.4). |
9 | EXERCISE OF OPTIONS: RESTRICTIONS |
9.1 | An Option Holder may not exercise an Option when its exercise is prohibited by, or would be a breach of any: |
(a) | law; |
(b) | regulation with the force of law; or |
(c) | rule of an investment exchange on which the Shares are listed or traded or rule, code or set of guidelines that binds the Company or with which Company has resolved to comply. |
9.2 | An Option Holder may not exercise an Option at any time when the Option Holder: |
(a) | has a Material Interest (any interests of the Option Holder's Associates being treated as belonging to the Option Holder for this purpose); or |
(b) | had a Material Interest in the 12 months before that time (any interests of the Option Holder's Associates being treated as having belonged to the Option Holder for this purpose). |
9.3 | An Option Holder may exercise an Option only if the Option Holder has: |
(a) | agreed to rule 12 in writing; and |
(b) | made any arrangements, or entered into any agreements, required under rule 12. |
9.4 | An Option Holder may not exercise an Option at any time: |
(a) | while subject to ongoing disciplinary proceedings by any Group Company; |
(b) | while any Group Company is investigating the Option Holder's conduct and may as a result begin disciplinary proceedings; |
(c) | while there is a breach of the Option Holder's employment contract that is a potentially fair reason for dismissal; |
(d) | while in breach of a fiduciary duty owed to any Group Company; |
(e) | after ceasing to be an Employee, if there was a breach of the employment contract or fiduciary duties that (in the reasonable opinion of the Board) would have prevented exercise of the Option had the Company been aware (or fully aware) of that breach, and of which the Company was not aware (or not fully aware) until after both: |
(i) | the Option Holder ceases to be an Employee; and |
(ii) | the time (if any) when the Board decided to permit exercise of the Option. |
9.5 | The Company shall apply the provisions of rule 9.4 in good faith and not frustrate a valid exercise of the Option by the inappropriate application of those provisions. |
9.6 | If an Option Holder is unable to exercise an Option due to the application of the provisions of rule 9.3, following the conclusion of any disciplinary proceedings or investigation, the Board shall determine whether the Option is exercisable. If so, the Option will be exercisable, subject to these rules, on the date of such determination. |
10 | TERMINATION OF EMPLOYMENT |
10.1 | Where an Option Holder gives or receives notice of termination of employment (whether or not lawful) before the Normal Vesting Date he/she may not exercise an Option while the notice remains effective, unless the Board determines otherwise. |
10.2 | An Option Holder who ceases employment with a Group Company may not exercise their Option except as permitted by |
(a) | Rule 10.6 (death); |
(b) | Rule 10.7 (miscellaneous); or |
(c) | Rule 10.11 (Board consent). |
10.3 | Where an Option Holder: |
(a) | dies while an Employee; or |
(b) | ceases to be an Employee (whether or not following notice and for whatever reason) |
10.4 | The number of Shares in respect of which the Option lapses shall be calculated in accordance with the formula N x (X/Y) where: |
(a) | N is the number of Shares in the original Option reduced by any Shares in respect of which it has already been exercised or has lapsed; |
(b) | X is the number of days between the Employee's date of death or cessation of employment and the Normal Vesting Date under the Option; and |
(c) | Y is the number of days between the Grant Date and the Normal Vesting Date under the Option. |
10.5 | The Shares after the reduction calculated in accordance with rule 10.4 shall be further reduced to reflect the extent to which the Performance Condition has not been satisfied on: |
(a) | the date on which the Board determines whether the Performance Condition has been met; and |
(b) | if an Option becomes exercisable before the Normal Vesting Date under this rule 10, the date the Option Holder ceased employment. |
10.6 | Notwithstanding any other rule of this Plan except rule 14.12 if an Option Holder dies, the Option Holder's personal representatives may exercise the Option over the Leaver Number during the period of 12 months following the Option Holder's death. If the Option is not exercised, it will lapse on the first anniversary of the Option Holder's death. |
10.7 | An Option Holder who ceases to be an Employee before the Normal Vesting date due to any of the following reasons, may exercise their Option over the Leaver Number during the 90-day period beginning on the earlier of the Normal Vesting Date and the date on which the Option becomes exercisable under rule 14: |
(a) | injury; |
(b) | ill health; |
(c) | disability; |
(d) | retirement; |
(e) | Redundancy; |
(f) | the Option Holder's employer ceasing to be a Group Company; or |
(g) | the transfer of the business that employs the Option Holder to a person that is not a Group Company, |
10.8 | An Option Holder who ceases to be an Employee before the Normal Vesting Date for any reason other than death or a reason specified in rule 10.7 may not exercise their Option unless the Board determines otherwise under rule 10.11. |
10.9 | An Option Holder who ceases to be an Employee on or after the Normal Vesting Date for any reason other than summary dismissal may exercise their Option during the period of 90 days following the date of cessation, after which the Option shall lapse to the extent not exercised. |
10.10 | An Option Holder who ceases to be an Employee by reason of summary dismissal may not exercise their Option unless the Board determines otherwise. |
10.11 | Where rules 10.8 or 10.10 apply, the Board may decide at any time during the period of 90 days after the relevant cessation of employment that the relevant Option Holder may exercise their Option over the Leaver Number. Any such decision, and whether to consider making such a decision, shall be entirely at the discretion of the Board. If the Board makes a decision to permit exercise under this rule 10.11, it shall: |
(a) | specify the period during which the Option may be exercised (after which the Option shall lapse, to the extent not exercised), such a period to end no later than the later of: |
(i) | the latest date on which the Option may be exercised, as specified in the Option Certificate; and |
(ii) | 90 days following the Normal Vesting Date; and |
(b) | notify the Option Holder of its decision within a reasonable time after making it. |
10.12 | An Option Holder shall not be regarded as ceasing to be an Employee for the purposes of this Plan until the Option Holder is no longer an Employee or director of any Group Company. |
11 | OPTION EXERCISE |
11.1 | An Option shall be exercised by the Option Holder giving a written exercise notice to the Company, that shall: |
(a) | set out the number of Shares over which the Option Holder wishes to exercise the Option. If that number exceeds the number over which the Option may be validly exercised at the time: |
(i) | the Option shall be treated as exercised only in respect of that lesser number; and |
(ii) | any excess amount paid to exercise the Option or meet any Tax Liability shall be refunded; |
(b) | be made using a form approved by the Board; |
(c) | include a power of attorney as required by rule 12.7; |
(d) | include the Option Holder's agreement to pay the Tax Liability in accordance with rule 12; and |
(e) | be accompanied by the relevant Option Certificate, save where the Board agrees otherwise upon such conditions as to the return and cancellation of the Option Certificate as the Board may in its absolute discretion decide. |
11.2 | An Option may be exercised in full or, where allowed under the grant document, in part in accordance with the terms of that grant. |
11.3 | Where an Option is exercised in part, the Company shall issue a new Option Certificate for the Shares that are still subject to the Option. |
11.4 | Any exercise notice shall be accompanied by: |
(a) | payment of an amount equal to the Exercise Price multiplied by the number of Shares specified in the notice; and |
(b) | any payment required under rule 12; and/or |
(c) | any documents relating to arrangements or agreements required under rule 12. |
11.5 | Any exercise notice shall be invalid: |
(a) | to the extent that it is inconsistent with the Option Holder's rights under these rules and the Option Certificate; |
(b) | if any of the requirements of rule 11.3 or rule 11.4 are not met; or |
(c) | if any payment referred to in rule 11.4 is made by a cheque that is not honoured on first presentation or in any other manner that fails to transfer the expected value to the Company. |
11.6 | The Company may permit the Option Holder to correct any defect referred to in rule 11.5(b) or (c) (but are not be obliged to do so). The date of any corrected exercise notice shall be the date of the correction rather than the original notice date for all other purposes of the Plan. |
11.7 | Shares shall be allotted and issued (or transferred, as appropriate) within 30 days after a valid Option exercise, subject to the other rules of the Plan. |
11.8 | Except for any rights determined by reference to a date before the date of allotment, Shares allotted and issued in satisfaction of the exercise of an Option shall rank equally in all respects with the other shares of the same class in issue at the date of allotment. |
11.9 | If the Shares are listed or traded on any stock exchange, the Company shall apply to the appropriate body for any newly issued Shares allotted on exercise of an Option to be admitted to trading on that exchange. |
12 | TAX LIABILITIES |
12.1 | The Option Holder shall indemnify the Employer Company in respect of any Tax Liability. |
12.2 | An Option Holder may not exercise an Option unless the Option Holder: |
(a) | agrees, in writing, to pay the Tax Liability to the Employer Company; and |
(b) | has made arrangements, satisfactory to the Employer Company or Company, to pay the Tax Liability. |
12.3 | If an Option Holder does not pay the Tax Liability within seven days of exercise, the Company or Employer Company as appropriate, may: |
(a) | if the Shares are readily saleable at the time, require that within a reasonable period specified by the Company the Option Holder: |
(i) | sell such number of Shares as is necessary to meet the Tax Liability and any costs of sale; and |
(ii) | remit the sum to the Company to meet the Tax Liability on the Option Holder's behalf and/or pay the sum directly to the relevant tax authority to whom the Tax Liability arises; or |
(b) | retain the amount of any Tax Liability from any payments of remuneration made to the Option Holder on or after the date on which the Tax Liability arose. However, in the case of national insurance contributions, the Employer Company may only withhold such amount as is permitted by law. |
12.4 | At the request of the Employer Company, at any time before exercise of the Option, the Option Holder must elect, to the extent permitted by law, and using a form approved by HMRC, that the whole or any part of the liability for employer national insurance contributions (Employer NICS) arising as a result of a Taxable Event shall be transferred to the Option Holder. |
12.5 | The Employer Company may: |
(a) | on the Grant Date, direct that the Tax Liability shall not include Employer NICs; or |
(b) | at any time after the Grant Date, but before the Option is exercised, release the Option Holder from their obligations in respect of Employer NICs under this rule 12 so that Employer NICs do not form part of the Tax Liability. |
12.6 | At the request of the Employer Company on or before the date of exercise of the Option, the Option Holder must enter into a joint election under section 431(1) or section 321(2) of ITEPA 2003, in respect of the Shares to be acquired on exercise of the relevant Option. |
12.7 | The exercise notice for the Option shall include a power of attorney appointing the Company as the Option Holder's agent and attorney for the purposes of rule 12.3. |
12.8 | Option Holders shall have no rights to compensation or damages on account of any loss in respect of Options or the Plan where such loss arises (or is claimed to arise), in whole or in part, from the Plan ceasing to be a Schedule 4 CSOP. |
12.9 | Each Option shall include a requirement that the Option Holder irrevocably agrees to enter into a joint election under section 431(1) or section 431(2) of ITEPA 2003, if required to do so by the Company, their employer or former employer, on or before the date of exercise of the Option. |
13 | RELATIONSHIP WITH EMPLOYMENT CONTRACT |
13.1 | The rights and obligations of any Option Holder under the terms of their office or employment with the Company (or any Group Company or former Group Company) shall not be affected by being an Option Holder. |
13.2 | The value of any benefit realised under the Plan by Option Holders shall not be taken into account in determining any pension, pension contribution, or similar entitlements. |
13.3 | Option Holders and Employees shall have no rights to compensation or damages on account of any loss in respect of Options or the Plan where such loss arises (or is claimed to arise), in whole or in part, from: |
(a) | termination of office or employment with; or |
(b) | notice to terminate office or employment given by or to, |
13.4 | Option Holders and Employees shall have no rights to compensation or damages from the Company, any Group Company or any former Group Company on account of any loss in |
(a) | any company ceasing to be a Group Company; or |
(b) | the transfer of any business from a Group Company to any person that is not a Group Company. |
13.5 | An Employee shall not have any right to receive Options, whether or not any have previously been granted. |
14 | TAKEOVERS AND LIQUIDATIONS |
14.1 | For the purposes of this rule 14 a Relevant Event means: |
(a) | a person (the Controller) obtaining Control of the Company as a result of: |
(i) | making a general offer to acquire the whole of the issued share capital of the Company (except for any capital already held by the Controller or any person connected with the Controller) that is made on a condition such that, if it is satisfied, the person making the offer will have Control of the Company; or |
(ii) | making a general offer to acquire all the shares in the Company (except for any shares already held by the Controller or any person connected with the Controller) that are of the same class as the Shares; or |
(b) | the court sanctioning a compromise or arrangement under section 899 of the Companies Act 2006 (or an equivalent compromise or arrangement in the relevant jurisdiction) that is applicable to or affects: |
(i) | all the ordinary share capital of the Company or all the Shares of the same class as the Shares to which the Option relates; or |
(ii) | all the Shares, or all the Shares of that same class, which are held by a class of shareholders identified otherwise than by reference to their employment or directorships or their participation in a Schedule 4 CSOP; or |
(c) | shareholders becoming bound by a non-UK reorganisation (as defined by paragraph 35ZA of Schedule 4) that is applicable to or affects: |
(i) | all the ordinary share capital of the Company or all the Shares of the same class as the Shares to which the Option relates; or |
(ii) | all the Shares, or all the Shares of that same class, which are held by a class of shareholders identified otherwise than by reference to their employment or directorships or their participation in a Schedule 4 CSOP; or |
(d) | a person becomes bound or entitled to acquire Shares under sections 979 to 985 of the Companies Act 2006. |
14.2 | Subject to rule 14.5 an Option may be exercised to the extent that the Performance Condition is met on the date of the Relevant Event: |
(a) | within six months of a Relevant Event occurring under rules 14.1(a), (b) or (c); or |
(b) | at any time after a Relevant Event occurring under rule 14.1(d), continuing for as long as that person remains so bound or entitled. |
14.3 | If: |
(a) | a Relevant Event specified in rule 14.1(a) occurs; or |
(b) | a change of Control occurs as a result of a Relevant Event specified in rules 14.1(b), (c) or (d); |
14.4 | If the Board reasonably expects a Relevant Event to occur, the Board may make arrangements permitting Options to be exercised for a period of 20 days ending with the Relevant Event. If an Option is exercised under this rule 14.4. it will be treated as having been exercised in accordance with rule 14.2. |
(a) | if the Option is not exercised in accordance with those arrangements, it will lapse on the date of the Relevant Event; and |
(b) | if the Relevant Event does not occur within 20 days of the date of purported exercise, the Option shall be treated as not having been exercised. |
14.5 | If, as a result of a Relevant Event, a company has obtained Control of the Company, each Option Holder may, by agreement with that company (Acquiring Company) within the Rollover Period, release each Option (Old Option) for a replacement option (New Option). A New Option shall: |
(a) | be over shares that satisfy the requirements of paragraphs 16 to 20 of Schedule 4 in the Acquiring Company (or some other company falling within paragraph 27(2)(b) of Schedule 4); |
(b) | be a right to acquire such number of those shares as have, immediately after grant of the New Option, a total Market Value substantially the same as the total Market Value of the shares subject to the Old Option immediately before its release; |
(c) | have an exercise price per share such that the total price payable on complete exercise of the New Option is substantially the same as the total price that would have been payable on complete exercise of the Old Option; and |
(d) | so far as practicable, be on terms otherwise identical to the Old Option immediately before the Old Option's release. |
14.6 | Any Rollover Period shall have the same duration as the applicable appropriate period defined in paragraph 26(3) of Schedule 4. |
14.7 | Any New Option granted under rule 14.5 shall be treated as having been acquired at the same time as the relevant Old Option for all other purposes of the Plan. |
14.8 | The Plan shall be interpreted in relation to any New Options as if references to: |
(a) | the Company were references to the Acquiring Company (or to any other company whose shares are subject to the New Options, as the context may require); and |
(b) | the Shares were references to the shares subject to the New Options. |
14.9 | The Company will remain the scheme organiser of the Plan (as defined in paragraph 2(2) of Schedule 4) following the release of Options and the grant of New Options under rule 14.5. |
14.10 | The Acquiring Company shall issue (or procure the issue of) an Option Certificate for each New Option. |
14.11 | In this rule 14 (other than rule 14.5), a person shall be deemed to have obtained Control of a company if they, and others acting with them, have obtained Control of it together. |
14.12 | If the shareholders of the Company receive notice of a resolution for the voluntary winding up of the Company, any Option Holder may exercise an Option to the extent that the Performance Condition is met at the date of the resolution at any time in the period before that resolution is passed, conditionally upon the passing of that resolution, and if the Option Holder does not exercise the Option, it shall lapse when the winding up begins. |
14.13 | Where there is a Relevant Event, or the Board reasonably expects a Relevant Event to occur, it shall have, in addition to the powers and discretions set out above, the powers and discretions set out in Article 9.3 of the US Plan (Corporate Transactions) (the Article 9.3 Powers) as if the UK Options were Awards under the US Plan, subject to the following limitations: |
(a) | the Article 9.3 Powers may not be used in such a way as calls into question or invalidates the Plan's status as a Schedule 4 CSOP and any such exercise will be void ab initio; |
(b) | the Article 9.3 Powers shall be exercised in such a way as to comply with any relevant legal requirements applicable in the jurisdiction of the Plan to the use of the powers; |
(c) | references in Article 9.3 to the Administrator shall be read as references to the Board; |
(d) | any payment made under paragraph (e) of Article 9.3 is subject to a requirement to provide the Option Holder with fair and appropriate value in exchange for the relevant Options (as determined reasonably by the Board) rather than be subject to the Board's absolute discretion; and |
(e) | the final paragraph of Article 9.3 and references to Code Section 409A in Article 9.3 shall not apply. |
14.14 | The Board shall notify Option Holders of any event that is relevant to Options under this rule 14 within a reasonable period after the Board becomes aware of it. |
15 | VARIATION OF SHARE CAPITAL |
15.1 | Subject to rule 15.2 and the requirements of paragraph 22 of Schedule 4: |
(a) | if there is any variation of the share capital of the Company (whether that variation is a capitalisation issue (other than a scrip dividend), rights issue, consolidation, subdivision or reduction of capital or otherwise) that affects (or may affect) the value of Options to Option Holders, the Board may adjust the number and description of Shares subject to each Option and/or the Exercise Price of each Option in a manner that the Board, in its reasonable opinion, considers to be fair and appropriate; and/or |
(b) | the Company may direct that the provisions of Article 9.1 (Adjustments) of the US Plan shall apply in respect of the Option. Where this rule 15.1(b) may apply in respect of an Option, the Option Certificate shall reference this possibility.) |
15.2 | Rule 15.1 is subject the following restrictions: |
(a) | adjustments to the Exercise Price may only be made in accordance with the provisions of paragraph 22 of Schedule 4; |
(b) | any adjustment to the number of Shares may be made only in accordance with either paragraph 22 of Schedule 4 or a mechanism notified to the Option Holder at grant; |
(c) | the total market value of the Shares subject to the Option is, immediately after the variation of share capital, substantially the same as immediately before the variation of share capital; |
(d) | the total amount payable on exercise of an Option immediately after the variation of Share Capital must be substantially the same as immediately before the variation of share capital; and |
(e) | the Exercise Price for a Share to be newly issued on the exercise of any Option shall not be reduced below its nominal value (unless the Board resolves to capitalise, from reserves, an amount equal to the amount by which the total nominal value of the relevant Shares exceeds the total adjusted Exercise Price, and to apply such amount to pay up the relevant Shares in full). |
16 | NOTICES |
16.1 | Any notice or other communication given under or in connection with the Plan shall be in writing and shall be: |
(a) | delivered by hand or by pre-paid international post at the appropriate address; |
(i) | in the case of the Company, at 3020 Carrington Mill Blvd., Suite 300, Morrisville, NC 27560; |
(ii) | in the case of an Option Holder, their home address as notified by the Option Holder to the Company; |
(iii) | if the Option Holder has died, and notice of the appointment of personal representatives has been given to the Company, any contact address they have specified in such notice; and |
(b) | sent by fax to the fax number notified in writing by the recipient to the sender; or |
(c) | sent by email to the appropriate email address, |
(i) | in the case of the Company, Bill.Alvey@maxpoint.com; |
(ii) | in the case of the Option Holder, if they are permitted to receive personal emails at work, their work email address, if not, the email notified to the Company by the Option Holder. |
16.2 | Any notice or other communication given under this rule 16 shall be deemed to have been received: |
(a) | if delivered by hand, on signature of a delivery receipt, or at the time the notice is left at the proper address; |
(b) | if sent by pre-paid international post, at 9.00 a.m. local time on the sixth Business Day after posting, or at the time recorded by the delivery service; |
(c) | if send by fax, at 9.00 a.m. local time on the next Business Day after transmission; and |
(d) | if sent by email, at 9.00 a.m. local time on the next Business Day after sending. |
16.3 | This rule 16 does not apply to: |
(a) | the service of any exercise notice pursuant to rule 11.2; and |
(b) | the service of any proceedings or other documents in any legal action or, where applicable, any arbitration or other method of dispute resolution. |
17 | ADMINISTRATION AND AMENDMENT |
17.1 | The Plan shall be administered by the Board. |
17.2 | The Board may amend the Plan from time to time, but: |
(a) | no amendment may be made to a Key Feature of the Plan if, as a result of the amendment, the Plan would no longer be a Schedule 4 CSOP; |
(b) | no material amendment may apply to Options granted before the amendment was made without the consent of the Option Holder; and |
(c) | no amendment may be made without the prior approval of the Company as required under the rules of its stock market listing, and/or the jurisdiction in which it is incorporated. |
17.3 | The Company shall ensure that at all times: |
(a) | it has sufficient unissued or treasury Shares available; or |
(b) | arrangements are in place for a third party to transfer issued Shares to satisfy the exercise of all the Options. |
(c) | arrangements are in place for any third party to transfer issued Shares, |
17.4 | The Board (whose decision is final) shall determine any question of interpretation and settle any dispute arising under the Plan. |
17.5 | The Board shall act fairly and reasonably and in good faith in making any decision or determination, or exercising any discretion under the rules, |
17.6 | The Company is not obliged to notify any Option Holder if an Option is due to lapse. |
17.7 | The Company is not obliged to provide Option Holders with copies of any materials sent to the holders of Shares. |
18 | GOVERNING LAW |
18.1 | The Plan and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales save that disputes or claims that relate to the provisions of the US Plan and/or the equivalent provision of any successor or replacement US plan, shall be governed by the laws of the State of Delaware. |
19 | JURISDICTION |
19.1 | Each party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with the Plan or its subject matter or formation (including non-contractual disputes or claims). |
19.2 | Each party irrevocably consents to any process in any legal action or proceedings under rule 19.1 above being served on it in accordance with the provisions of the Plan relating to service of notices. Nothing contained in the Plan shall affect the right to serve process in any other manner permitted by law. |
20 | THIRD PARTY RIGHTS |
20.1 | Save where provided otherwise under this Plan in respect of employers or former employers of an Option Holder, persons who are not parties to the Option shall have no rights under or in connection with it as a result of the Contracts (Rights of Third Parties) Act 1999. |
20.2 | The rights of the parties to an Option to surrender, terminate or rescind it, or agree any variation, waiver or settlement of it, are not subject to the consent of any person that is not a party to the Option as a result of the Contracts (Rights of Third Parties) Act 1999. |
21 | DATA PROTECTION |
21.1 | In accepting the grant of an Option each Option Holder consents to the collection, holding, processing and transfer of their Personal Data by the Company or any Constituent Company for all purposes connected with the operation of the Plan. |
21.2 | The purposes of the Plan referred to in rule 21.1 include, but are not limited to: |
(a) | holding and maintaining details of the Option Holder's Options; |
(b) | transferring the Option Holder's Personal Data to the trustee of an employee benefit trust, the Company's registrars or brokers or any administrators of the Plan; |
(c) | transferring the Option Holder's Personal Data to a bona fide prospective buyer of the Company or the Option Holder's employer company or business unit (or the prospective buyer's advisers), provided that the prospective buyer and its advisers irrevocably agree to use the Option Holder's Personal Data only in connection with the proposed transaction and in accordance with the data protection principles set out in the Data Protection Act 1998; and |
(d) | transferring the Option Holder's Personal Data under rules 21.2(b) or (c) to a person (in particular the Group Companies) who are resident in a country or territory outside the European Economic Area that may not provide the same statutory protection for the information as countries within the European Economic Area. |
21.3 | The Plan shall be administered in accordance with any relevant Data Protection Law applicable in the United Kingdom from time to time. |
Share Option Agreement under the MaxPoint Interactive, Inc Company Share Option Plan | |
Dated [ ] | |
MaxPoint Interactive, Inc (The Company) | |
(1) | This is a deed of MaxPoint Interactive, Inc (the Company) incorporated under the laws of the State of Delaware, whose principal place of business is in Morrisville, North Carolina, U.S.A. |
1 | Interpretation |
1.1 | Words in this Option Certificate shall have the same meaning as in the Plan, save where they are specified to have a different meaning under this Option Certificate, or where the context otherwise requires. |
1.2 | The rules of interpretation in the Plan also apply to this Option Certificate. |
1.3 | A copy of the rules of the Plan may be obtained on request from [ ]. |
1.4 | References to "you" or "your" refer or address the Option Holder. |
2 | Grant of Option |
2.1 | Subject to the other terms of the Option Certificate and the rules of the Plan, the Company grants you an option (Option) to acquire [number of shares] (Option Shares) in the Company. |
2.2 | The Grant Date of the Option is the date of execution of this deed. |
2.3 | The Exercise Price of the Option is [CURRENCY UNIT][AMOUNT] per Option Share. |
3 | Earliest exercise date |
3.1 | You may not exercise the Option before the Normal Vesting Date unless an event occurs before then which causes the Option to become exercisable under the rules of the Plan. |
3.2 | You may lose the ability to exercise the Option and/or the Option may lapse before the Normal Vesting Date if certain events occur, in accordance with the rules of the Plan. |
4 | Latest exercise date |
4.1 | You may not exercise the Option after [date within 10 years of date of grant] and it will lapse on that date if it has not lapsed or been exercised in full before then. [DN – no more than 10 years from date of grant to retain CSOP tax relief) |
4.2 | You may lose the ability to exercise the Option and/or the Option may lapse before the date specified in clause 4.1 if certain events occur, in accordance with the rules of the Plan. |
5 | Performance conditions [DN – Omit if no Performance conditions set] |
5.1 | You may only exercise the Option if, and to the extent that, the performance conditions set out in Schedule 1 to this deed (Performance Conditions) are satisfied. |
5.2 | The Rules of the Plan set out the circumstances (if any) where the Company may waive or vary these performance conditions. |
6 | Restrictions applying to shares to the Option Shares |
7 | Option terms |
7.1 | The Option is subject to: |
(a) | the legislation applicable to Schedule 4 CSOP schemes; and |
(b) | the rules of the Plan (which are also subject to that legislation). |
7.2 | The provisions referenced in clause 7.1 shall take precedence over any other conflicting statement about the terms of the Option |
8 | Restrictions on transfer and charging |
8.1 | You may not transfer the Option and it will lapse if you attempt to do so. However, the Option will not lapse if and when it passes to your personal representatives on your death. |
8.2 | You may not make the Option subject to a charge or any other security interest. The Option will lapse if you attempt to do so. |
8.3 | The Option will lapse if you are declared bankrupt. |
9 | Limits on exercise |
(a) | cease holding office or employment with a Group Company; or |
(b) | give or receive notice to terminate office or employment |
10 | Exercise after cessation of employment |
(a) | after you cease holding office or employment with a Group Company; or |
(b) | after you give or receive notice to terminate employment with a Group Company. |
11 | Terms of employment |
11.1 | The grant and existence of the Option shall not affect the terms of your employment with the Company or any other company of which the Company has (or had) Control. |
11.2 | You shall have no rights to compensation or damages on account of any loss concerning the Option or the Plan that arises (or is claimed to arise), in whole or in part, from: |
(a) | the termination of any office or employment held by you; or |
(b) | any notice to terminate office or employment given by or to you; or |
(c) | any company ceasing to be a Constituent Company of the Plan; or |
(d) | the transfer of any business to a person which is not a Constituent Company of the Plan; or |
(e) | a determination by HMRC that the Plan is no longer a Schedule 4 CSOP scheme. |
11.3 | This clause 11 applies however the relevant circumstances are caused and however damages or compensation may be claimed. |
11.4 | The grant of the Option does not give you any right to receive further options under the Plan, or any other share incentives or bonuses. |
11.5 | The value of any benefit realised from the Option will not be taken into account in determining your entitlement to any pension or similar benefit. |
12 | Tax and National Insurance Contributions |
12.1 | On exercise of the Option you may have an income tax liability under PAYE and you may be required to pay National Insurance contributions (NICs). Where this is the case: |
(a) | the Company (or your employer, if different) may require you to pay amounts in respect of your PAYE and NICs liability, or enter into some other arrangement specified by the Company for the payment of these amounts; |
(b) | You may be required to: |
(i) | pay; or |
(ii) | enter into a joint election to transfer; or |
(iii) | enter into an arrangement or agreement for the payment of |
(c) | in some circumstances, the Company may withhold the number of Option Shares required to meet your liabilities in respect of PAYE, and primary (employee) class 1 NICs and secondary (employer) class 1 NICs. |
12.2 | The Option may only be exercised if you: |
(a) | confirm (in writing) that you agree to the requirements of the Plan relating to PAYE and NICs This may be done at the time of exercise; and |
(b) | make any arrangements, or enter into any agreements, that may be required under this rule 12 of the Plan (tax liabilities). |
13 | Exercise of Option |
13.1 | To exercise the Option, you should fill in and sign an exercise notice and submit it to the Company. |
13.2 | An exercise notice form can be obtained from [name of person]. |
Name of Optionee: | «Name» |
Total Number of Shares: | «Number_of_Option_Shares_Granted» |
Exercise Price per Share: | «Price per share» |
Date of Grant: | «Grant_Date» |
Vesting Commencement Date: | «Vesting_Date» |
Vesting Schedule: | «To be completed» |
Expiration Date: | «Expiration Date». This option expires earlier if your Service terminates earlier, as described in the Stock Option Agreement, and may terminate earlier in connection with certain corporate transactions as described in Article 9 of the Plan. |
Grant of Option | Subject to all of the terms and conditions set forth in the Notice of Stock Option Grant, this Stock Option Agreement (the “Agreement”) and the Plan, the Company has granted you an option to purchase up to the total number of shares specified in the Notice of Stock Option Grant at the exercise price indicated in the Notice of Stock Option Grant. All capitalized terms used in this Agreement shall have the meanings assigned to them in this Agreement, the Notice of Stock Option Grant or the Plan. |
Vesting | This option vests and becomes exercisable in accordance with the vesting schedule set forth in the Notice of Stock Option Grant. In no event will this option vest or become exercisable for additional shares after your Service has terminated for any reason. |
Term | This option expires in any event at the close of business at Company headquarters on the day before the 10th anniversary of the Date of Grant, as shown in the Notice of Stock Option Grant. (This option will expire earlier if your Service terminates, as described below, and this option may be terminated earlier as provided in Article 9 of the Plan.) |
Termination of Service | If your Service terminates for any reason, this option will expire immediately to the extent the option is unvested as of your termination date and does not vest as a result of your termination of Service. The Company determines when your Service terminates for all purposes of this option. You understand and acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement. |
Regular Termination | If your Service terminates for any reason except death or total and permanent disability, then this option, to the extent vested as of your termination date, will expire at the close of business at Company headquarters on the date three months after your termination date. |
Death | If you die before your Service terminates, then this option will expire at the close of business at Company headquarters on the date 12 months after the date of death. |
Disability | If your Service terminates because of your total and permanent disability, then this option will expire at the close of business at Company headquarters on the date 12 months after your termination date. For all purposes under this Agreement, “total and permanent disability” means that you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of not less than one year. |
Leaves of Absence and Part-Time Work | For purposes of this option, your Service does not terminate when you go on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of Service is required by applicable law, the Company’s leave of absence policy, or the terms of your leave. However, your Service terminates when the approved leave ends, unless you immediately return to active work. If you go on a leave of absence, then the vesting schedule specified in the Notice of Stock Option Grant may be adjusted in accordance with the Company’s leave of absence policy or the terms of your leave. If you commence working on a part-time basis, the Company may adjust the vesting schedule so that the rate of vesting is commensurate with your reduced work schedule. |
Restrictions on Exercise | The Company will not permit you to exercise this option if the issuance of shares at that time would violate any law or regulation. |
Notice of Exercise | When you wish to exercise this option, you must notify the Company by filing the proper “Notice of Exercise” form at the address given on the form or, if the Company has designated a brokerage firm to administer the Plan, you must notify such brokerage firm in the manner such brokerage firm requires. Your notice must specify how many shares you wish to purchase. The notice will be effective when the Company receives it. However, if you wish to exercise this option by executing a same-day sale (as described below), you must follow the instructions of the Company and the broker who will execute the sale. If someone else wants to exercise this option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so. You may only exercise your option for whole shares. |
Form of Payment | When you submit your notice of exercise, you must include payment of the option exercise price for the shares that you are purchasing. To the extent permitted by applicable law, payment may be made in one (or a combination of two or more) of the following forms: • By delivering to the Company your personal check, a cashier’s check or a money order, or arranging for a wire transfer. • By delivering to the Company certificates for shares of Company stock that you own, along with any forms needed to effect a transfer of those shares to the Company. The value of the shares, determined as of the effective date of the option exercise, will be applied to the option exercise price. Instead of surrendering shares of Company stock, you may attest to the ownership of those shares on a form provided by the Company and have the same number of shares subtracted from the option shares issued to you. • By giving to a securities broker approved by the Company irrevocable directions to sell all or part of your option shares and to deliver to the Company, from the sale proceeds, an amount sufficient to pay the option exercise price and any withholding taxes. (The balance of the sale proceeds, if any, will be delivered to you.) The directions must be given in accordance with the instructions of the Company and the broker. This exercise method is sometimes called a “same-day sale.” |
Tax Matters | The liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax‑related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”) is and remains your responsibility and may exceed the amount actually withheld by your employer (either the Company, a Subsidiary or such other employer, as applicable, the “Employer”). You will not be allowed to exercise this option unless you make prior arrangements acceptable to the Company and the Employer to pay any withholding taxes that may be due as a result of the option exercise. These arrangements include payment in cash or cash equivalents. With the Company’s consent, these arrangements may also include (a) payment from the proceeds of the sale of shares through a Company-approved broker (on your behalf pursuant to this authorization without further consent), (b) withholding shares of Company stock that otherwise would be issued to you when you exercise this option with a fair market value no greater than the minimum amount required to be withheld by law, (c) surrendering shares that you previously acquired with a fair market value no greater than the minimum amount required to be withheld by law, or (d) withholding cash from your other compensation (pursuant to this authorization without further consent). The fair market value of withheld or surrendered shares, determined as of the date when taxes otherwise would have been withheld in cash, will be applied to the withholding taxes. You further acknowledge that the Company and the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of your option, including, but not limited to, the grant, vesting or exercise of your option, the subsequent sale of shares of Common Stock acquired pursuant to such exercise and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of your option to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that the Company or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. Finally, you agree to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares or the proceeds of the sale of shares if you fail to comply with your obligations in connection with the Tax-Related Items. |
Joint Election for Transfer of Liability for Employer National Insurance Contributions. As a condition of participation in the Plan and the exercise of your option, you agree to accept any liability for secondary Class 1 National Insurance contributions that may be payable by the Company (or any Subsidiary) in connection with your option and any event giving rise to such tax obligation (“Employer NICs”). Without prejudice to the foregoing, you agree to execute a joint election with the Company or the Employer, once the form of such joint election (the “Joint Election”) has been approved formally by HMRC, and any other required consent or election prior to exercise of the option. You further agree to execute such other joint elections as may be required between you and any successor to the Company or any Subsidiary, including the Employer. You further agree that the Company and any Subsidiary, including the Employer, may collect the Employer NICs from you by any of the means set forth above. If you do not enter into a Joint Election prior to the exercise of your option, you will not be entitled to exercise the option unless and until you enter into a Joint Election, and no shares will be issued to you under the Plan, without any liability to the Company or any Subsidiary, including the Employer. | |
Tax Consequences | You agree that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You shall not make any claim against the Company or its Board, officers or employees related to tax liabilities arising from this option or your other compensation. In particular, if you are subject to U.S. taxation you acknowledge that this option is exempt from Section 409A of the Code only if the Exercise Price is at least equal to the Fair Market Value per Common Share on the Date of Grant. |
Restrictions on Resale | You agree not to sell any option shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify. |
Transfer of Option | Prior to your death, only you may exercise this option. You cannot transfer or assign this option. For instance, you may not sell this option or use it as security for a loan. If you attempt to do any of these things, this option will immediately become invalid. You may, however, dispose of this option in your will or by means of a written beneficiary designation; provided, however, that your beneficiary or a representative of your estate acknowledges and agrees in writing in a form reasonably acceptable to the Company, to be bound by the provisions of this Agreement and the Plan as if such beneficiary of the estate were you. Regardless of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your former spouse, nor is the Company obligated to recognize your former spouse’s interest in your option in any other way. |
Retention Rights | Your option or this Agreement does not give you the right to be retained by the Company, a Parent, Subsidiary, or an Affiliate in any capacity. The Company and its Parents, Subsidiaries, and Affiliates reserve the right to terminate your Service at any time, with or without cause. |
Stockholder Rights | You, or your estate or heirs, have no rights as a stockholder of the Company until you have exercised this option by giving the required notice to the Company, paying the exercise price, and satisfying any applicable withholding taxes. No adjustments are made for dividends or other rights if the applicable record date occurs before you exercise this option, except as described in the Plan. |
Recoupment Policy | This option, and the shares acquired upon exercise of this option, shall be subject to any Company recoupment policy in effect from time to time. |
Adjustments | In the event of a stock split, a stock dividend or a similar change in Company stock, the number of shares covered by this option and the exercise price per share will be adjusted pursuant to the Plan. |
Effect of Significant Corporate Transactions | If the Company is a party to a merger, consolidation, or certain change in control transactions, then this option will be subject to the applicable provisions of Article 9 of the Plan. |
Applicable Law | This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to its choice-of-law provisions). |
Extraordinary Compensation | The value of this option shall be an extraordinary item of compensation outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. |
Personal Data Authorization | You consent to the collection, use and transfer of personal data as described in this Subsection. You understand and acknowledge that the Company, your employer and the Company’s other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering the Plan, including (without limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any shares or directorships held in the Company and details of all options or any other entitlements to shares awarded, canceled, exercised, vested, unvested or outstanding in your favor (the “Data”). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection by contacting the Company in writing. |
Electronic Delivery |
Plan Discretionary | You understand and acknowledge that (i) the Plan is entirely discretionary, (ii) the Company and your employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not in any way create any contractual or other right to receive additional grants of options (or benefits in lieu of options) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when options will be granted, the number of shares offered, the Exercise Price and the vesting schedule, will be at the sole discretion of the Company. |
Authorization to Disclose | You hereby authorize and direct your employer to disclose to the Company or any Subsidiary any information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation in the Plan, as your employer deems reasonably necessary or appropriate to facilitate the administration of the Plan. |
The Plan and Other Agreements | The text of the Plan is incorporated in this Agreement by reference. This Plan, this Agreement and the Notice of Stock Option Grant constitute the entire understanding between you and the Company regarding this option. Any prior agreements, commitments or negotiations concerning this option are superseded. This Agreement may be amended only by another written agreement between the parties. |
1. | I have reviewed this quarterly report on Form 10-Q of MaxPoint Interactive, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(c) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 10, 2016 | By: | /s/ Joseph Epperson |
Name: | Joseph Epperson | |
Title: | President, Chief Executive Officer and Chairman | |
(Principal Executive Officer) |
1. | I have reviewed this quarterly report on Form 10-Q of MaxPoint Interactive, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(c) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 10, 2016 | By: | /s/ Brad Schomber |
Name: | Brad Schomber | |
Title: | Chief Financial Officer | |
(Principal Financial and Accounting Officer) |
(1) | The quarterly report on Form 10-Q for the Company for the quarter ended September 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 10, 2016 | By: | /s/ Joseph Epperson |
Name: | Joseph Epperson | |
Title: | President, Chief Executive Officer and Chairman | |
(Principal Executive Officer) |
(1) | The quarterly report on Form 10-Q for the Company for the quarter ended September 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 10, 2016 | By: | /s/ Brad Schomber |
Name: | Brad Schomber | |
Title: | Chief Financial Officer | |
(Principal Financial and Accounting Officer) |
Document and Entity Information - shares |
9 Months Ended | |
---|---|---|
Sep. 30, 2016 |
Nov. 04, 2016 |
|
Document And Entity Information | ||
Entity Registrant Name | MAXPOINT INTERACTIVE, INC. | |
Entity Central Index Key | 0001611231 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2016 | |
Document Fiscal Year Focus | 2016 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 6,631,639 | |
Entity Current Reporting Status | Yes |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares |
Sep. 30, 2016 |
Dec. 31, 2015 |
---|---|---|
Common stock | ||
Common shares par value (in usd per share) | $ 0.00005 | $ 0.00005 |
Common shares authorized | 500,000,000 | 500,000,000 |
Common shares issued | 6,605,137 | 6,560,987 |
Common shares outstanding | 6,605,137 | 6,560,987 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Income Statement [Abstract] | ||||
Revenue | $ 37,418 | $ 35,969 | $ 102,807 | $ 99,135 |
Traffic acquisition costs | 12,489 | 12,935 | 35,352 | 38,053 |
Other cost of revenue | 5,135 | 4,280 | 14,710 | 10,863 |
Gross profit | 19,794 | 18,754 | 52,745 | 50,219 |
Operating expenses: | ||||
Sales and marketing | 11,182 | 12,883 | 37,736 | 38,521 |
Research and development | 7,083 | 6,127 | 20,671 | 16,206 |
General and administrative | 4,188 | 4,347 | 13,889 | 11,442 |
Total operating expenses | 22,453 | 23,357 | 72,296 | 66,169 |
Loss from operations | (2,659) | (4,603) | (19,551) | (15,950) |
Other expense (income): | ||||
Interest expense | 261 | 190 | 761 | 1,060 |
Interest income | 0 | 0 | (3) | 0 |
Amortization and write-off of debt discount | 0 | 0 | 0 | 1,108 |
Amortization and write-off of deferred financing costs | 11 | 8 | 39 | 189 |
Derivative fair value adjustment related to common stock warrants | 0 | 0 | 0 | (482) |
Total other expense | 272 | 198 | 797 | 1,875 |
Loss before income taxes | (2,931) | (4,801) | (20,348) | (17,825) |
Provision for income taxes | 0 | 0 | 0 | 0 |
Net loss | $ (2,931) | $ (4,801) | $ (20,348) | $ (17,825) |
Net loss per basic and diluted share of common stock (in usd per share) | $ (0.44) | $ (0.74) | $ (3.09) | $ (3.50) |
Weighted-average shares used to compute net loss per basic and diluted share of common stock | 6,599,233 | 6,485,755 | 6,582,118 | 5,089,110 |
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (2,931) | $ (4,801) | $ (20,348) | $ (17,825) |
Other comprehensive loss: | ||||
Foreign currency translation adjustments | (22) | (22) | (97) | (14) |
Comprehensive loss | $ (2,953) | $ (4,823) | $ (20,445) | $ (17,839) |
Description of Business |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | Description of Business Organization MaxPoint Interactive, Inc. (the "Company") was incorporated in September 2006 under the state laws of Delaware. The Company is a provider of a business intelligence and marketing automation solution. The Company’s customers are located in the United States and Europe and consist primarily of enterprises with national brands in the consumer products, retail, automotive, financial services, healthcare, telecommunications and entertainment industries. The Company’s MaxPoint Intelligence Platform predicts the most likely local buyers of a specific product at a particular retail location and then executes cross-channel digital marketing campaigns to reach these buyers on behalf of the Company’s customers. The Company is headquartered in Morrisville, North Carolina and has offices across the United States and one in the United Kingdom. Reverse Stock Split On April 25, 2016, the Company amended its amended and restated certificate of incorporation effecting a 1-for-4 reverse stock split of its outstanding shares of capital stock. The reverse stock split did not change the number of authorized shares of capital stock of the Company or cause an adjustment to the par value of the Company's capital stock. As a result of the reverse stock split, the Company was required to adjust the share amounts under its equity incentive plans and common stock warrant agreements with third parties. No fractional shares were issued in connection with the reverse stock split. Stockholders who would have otherwise held a fractional share of capital stock received a cash payment for any fractional share resulting from the split in an amount equal to such fraction multiplied by the closing sales price of the common stock as reported on the New York Stock Exchange on April 25, 2016, the last trading day immediately prior to the split. All disclosures of shares and per share data in the condensed consolidated financial statements and related notes have been adjusted to reflect the reverse stock split for all periods presented. Stock Exchange Listing Transfer On May 2, 2016, the Company provided written notice to the New York Stock Exchange of its intention to voluntarily delist its common stock on the New York Stock Exchange and to list its common stock on the Nasdaq Global Market ("Nasdaq"). The common stock was approved for listing on Nasdaq, with its continued trading under the symbol "MXPT." Trading of the Company’s common stock commenced on Nasdaq on May 13, 2016. Stock Repurchase Program On March 4, 2016, the Company's board of directors authorized the repurchase of up to $4.0 million of the Company's outstanding shares of common stock. As part of the share repurchase program, shares may be purchased in open market transactions, including through block purchases, through privately negotiated transactions, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The stock repurchase program requires that the Company retire repurchased shares in accordance with Delaware corporate law and that such repurchased shares resume the status of authorized but unissued shares of common stock. The Company accounts for stock repurchases using the constructive retirement method wherein the aggregate par value of the stock is recorded to common stock and the excess of cost over par value is recorded to additional paid-in capital, subject to its pro rata portion. For the nine months ended September 30, 2016, the Company repurchased 15,197 shares under this program at a weighted-average price per share of $8.19. The Company did not repurchase any shares under this program during the three months ended September 30, 2016. As of September 30, 2016 the Company had the ability to repurchase up to approximately $3.9 million of common stock under the program. |
Summary of Significant Accounting Policies |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany accounts and transactions have been eliminated in consolidation. Basis of Presentation The condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company believes that its existing cash balances, together with its current revolving line of credit, which was recently amended to, among other things, extend the maturity date to December 31, 2017, will be sufficient to meet its anticipated cash requirements through at least the next 12 months. The Company has historically incurred losses and negative cash flows from operations and its line of credit requires the Company to comply with certain covenants, as described in Note 4. The Company’s liquidity needs will largely be determined by the success of its products already being marketed and innovations that it is currently working on, including: increasing the share of spending from its existing customers, acquiring new customers, and further penetrating new industries. If these efforts are not successful or the Company does not meet its operating plan or continue its compliance with its debt covenants, it will likely be necessary to do one or more of the following: (a) raise additional capital through equity or debt financings; (b) raise additional capital from other sources; or (c) reduce operating expenditures. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. The Company evaluates its estimates, including those related to its allowance for doubtful accounts, revenue recognition, internal-use software, stock-based compensation, income taxes and related valuation allowances and the fair value of common stock warrants. The Company bases its estimates on its historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Actual results could differ from those estimates. Unaudited Interim Condensed Consolidated Financial Information The condensed consolidated financial statements and footnotes have been prepared in accordance with GAAP as contained in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and applicable rules and regulations of the Securities and Exchange Commission’s ("SEC") Rule 10-01 of Regulation S-X for interim financial information. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of financial position, the results of operations, comprehensive loss, changes in stockholders’ equity and cash flows. The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the results for the full year or the results for any future periods. The accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015 ("Form 10-K"). The significant accounting policies and recent accounting pronouncements were described in Note 2 to the consolidated financial statements included in the Form 10-K. There have been no significant changes in or updates to the accounting policies since December 31, 2015. Restricted Cash Restricted cash represents cash that is subject to contractual withdrawal restrictions and penalties. Restricted cash is classified within the condensed consolidated balance sheets based on the timing of when the restrictions are expected to lapse. The Company presented restricted cash related to its debt agreement in the condensed consolidated balance sheets based on timing of maturity. On March 8, 2016, the Company amended its Amended New Loan and Security Agreement. The second amendment to the Amended New Loan and Security Agreement changed certain terms and conditions to the Amended New Loan and Security Agreement and Amended New Revolving Line of Credit. This amendment, among other things, removed the $5.0 million minimum cash and availability requirement (defined as cash held at the lender plus the unused credit line availability amount). As such, no amounts were reflected as restricted cash within the condensed consolidated balance sheets as of September 30, 2016. The Company had recorded $1.9 million of restricted cash as of December 31, 2015 based on its availability under the Amended New Loan and Security Agreement of $3.1 million as of that date. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and accounts receivable. All of the Company’s cash and cash equivalents are held at financial institutions that management believes to be of high credit quality. The Company’s cash and cash equivalent accounts exceed federally insured limits. The Company has not experienced any losses on cash and cash equivalents to date. To manage accounts receivable risk, the Company evaluates and monitors the creditworthiness of its customers. As of December 31, 2015 and September 30, 2016, the Company did not have any customers or advertising agencies that individually comprised a significant concentration of its accounts receivable. For the three and nine months ended September 30, 2015 and 2016, the Company did not have any customers that individually comprised a significant concentration of its revenue. Allowance for Doubtful Accounts The Company extends credit to its customers without requiring collateral. Accounts receivable are stated at net realizable value. The Company utilizes the allowance method to provide for doubtful accounts based on management’s evaluation of the collectability of amounts due. The Company’s estimate is based on historical collection experience and the current status of accounts receivable. Historically, actual write-offs for uncollectible accounts have not significantly differed from the Company’s estimates. At December 31, 2015 and September 30, 2016, the Company had reserved for $0.1 million and $0.3 million of its accounts receivable balance, respectively. The following table presents the changes in the allowance for doubtful accounts for the three and nine months ended September 30 (in thousands):
Internal-Use Software Development Costs The Company capitalizes certain costs associated with software developed for internal use, primarily consisting of direct labor costs associated with creating the software. Software development projects generally include three stages: the preliminary project stage (all costs are expensed as incurred); the application development stage (certain costs are capitalized and certain costs are expensed as incurred); and the post-implementation/operation stage (all costs are expensed as incurred). Costs capitalized in the application development stage primarily include costs of designing, coding and testing the software. Capitalization of costs requires judgment in determining when a project has reached the application development stage and the period over which the Company expects to benefit from the use of that software. Once the software is placed in service, these capitalized costs are amortized using the straight-line method over the estimated useful life of the software. Internal-use software development costs of $1.6 million and $1.7 million were capitalized during the three months ended September 30, 2015 and 2016, respectively. Internal-use software development costs of $4.7 million and $5.5 million were capitalized during the nine months ended September 30, 2015 and 2016, respectively. Capitalized internal-use software development costs are included in property, equipment and software, net in the condensed consolidated balance sheets. Amortization expense related to the capitalized internal-use software was $0.6 million and $1.3 million for the three months ended September 30, 2015 and 2016, respectively, and $1.8 million and $3.5 million for the nine months ended September 30, 2015 and 2016, respectively, and is primarily included in other cost of revenue and research and development expense in the condensed consolidated statements of operations. The net book value of capitalized internal-use software was $9.8 million and $11.7 million at December 31, 2015 and September 30, 2016, respectively. Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. This accounting standards update is to simplify the presentation of debt issuance cost. This new guidance requires that debt issuance cost related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the treatment of debt discounts. The accounting standards update does not affect the recognition and measurement guidance for debt issuance costs. In August 2015, the FASB issued ASU 2015-15, Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. This accounting standards update states that given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line of credit arrangements, the SEC would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the debt issuance costs ratably over the term of the line of credit arrangement, regardless of whether there are any outstanding borrowings on the line of credit arrangement. The Company adopted ASU 2015-03, effective January 1, 2016, on a retrospective basis. The adoption of these pronouncements did not have a material impact on the Company's consolidated results of operations, financial position or cash flows. Recent Accounting Pronouncements Not Yet Adopted In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. The new standard provides a single principles-based, five-step model to be applied to all contracts with customers, which steps are to (1) identify the contract(s) with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when each performance obligation is satisfied. More specifically, revenue will be recognized when promised goods or services are transferred to the customer in an amount that reflects the consideration expected in exchange for those goods or services. This guidance states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09 for all entities by one year. In March 2016, the FASB issued ASU 2016-08, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU 2016-10, which clarifies the implementation guidance on identifying performance obligations and licensing. In May 2016, the FASB issued ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, which rescinds SEC paragraphs pursuant to SEC staff announcements. These rescissions include changes to topics pertaining to accounting for shipping and handling fees and costs and accounting for consideration given by a vendor to a customer. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, which amends certain aspects of the new revenue recognition standard pursuant to ASU 2014-09. ASU 2014-09, as amended by ASU 2015-14, is effective for interim or annual periods beginning after December 15, 2017. Early adoption of the standard is permitted, but not before the original effective date. Companies can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company plans to adopt ASU 2014-09 as of January 1, 2018. The Company is currently in the process of evaluating the impact that the adoption of ASU 2014-09 will have on its consolidated results of operations, financial position and cash flows, and selecting the method of transition to the new standard. In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. This guidance addresses management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim periods within annual periods beginning after December 15, 2016. Although early adoption was permitted, the Company did not early adopt this standard. The Company is currently evaluating the impact the update will have on its consolidated financial statements and related disclosures. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. This accounting standards update simplifies the presentation of deferred income taxes by eliminating the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. ASU 2015-17 requires an entity to classify deferred income tax liabilities and assets, as well as any related valuation allowance, as noncurrent within a classified balance sheet. This accounting standards update becomes effective for interim or annual periods beginning after December 15, 2016, and can be applied retrospectively or prospectively. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The purpose of this guidance is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance supersedes previous accounting guidance under Topic 840. Under ASU 2016-02, a lessee will be required to recognize assets and liabilities for the rights and obligations created by leases for leases with lease terms of more than 12 months. Lessor accounting remains substantially similar to current GAAP. In addition, disclosures of leasing activities are to be expanded to include qualitative along with specific quantitative information. ASU 2016-02 is effective for interim or annual periods beginning after December 15, 2018 and early adoption is permitted. This standard requires lessees and lessors to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for interim or annual periods beginning after December 15, 2016 and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments. This new standard provides guidance related to eight specific cash flow issues, with the objective of reducing diversity in practice of how certain cash receipts and payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for interim or annual periods beginning after December 15, 2017 and early adoption is permitted. ASU 2016-15 must be applied retrospectively, unless it is impracticable to do so, in which case the amendments would be applied prospectively as of the earliest date practicable. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. |
Fair Value Measurements |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued expenses and other current liabilities, approximate their respective fair values due to their short term nature. The Company's debt contains a variable rate of interest as of September 30, 2016 and therefore the carrying value of debt approximates its fair value. The fair value of debt falls within Level 3 of the fair value hierarchy as it is significantly driven by the creditworthiness of the Company, which is an unobservable input. The fair value of the money market fund measured using level 1 inputs in the fair value hierarchy reflected in cash and cash equivalents in the condensed consolidated balance sheets was $18.6 million as of December 31, 2015. As of September 30, 2016, the Company did not have a balance in this money market fund as all cash balances were maintained in demand deposit accounts. |
Debt |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Debt Disclosure [Abstract] | |
Debt | Debt On September 30, 2016, the Company entered into a third amendment to its Amended New Loan and Security Agreement (the "Third Amended New Loan and Security Agreement"). The Third Amended New Loan and Security Agreement changed the following terms and conditions to the Amended New Loan and Security Agreement and Amended New Revolving Line of Credit (the "Third Amended New Revolving Line of Credit") by: (1) extending the maturity date to December 31, 2017; (2) including in the revolving line of credit borrowing base calculation certain eligible unbilled accounts receivable; (3) adjusting the borrowing base calculation to be (a) 85% of eligible accounts receivable, plus (b) the lesser of (i) 75% of eligible unbilled accounts or (ii) $12,250,000; (4) modifying the definition of eligible accounts receivable for the revolving line of credit borrowing base by including up to 25% of certain eligible foreign accounts receivable, including those payable from Canada, Australia, France, Germany, Israel, Italy, Japan and the United Kingdom; (5) providing that all future cash collections from accounts receivable directly reduce the outstanding balance of the revolving credit facility; (6) fixing the applicable interest rate on future outstanding amounts under the revolving line of credit to a rate per annum equal to the prime referenced rate plus 0.5%; (7) reducing certain financial covenants regarding the required monthly minimum adjusted quick ratio, as defined and described below, in addition to removing certain previous ratio thresholds which could have resulted in a range of applicable interest rates; and (8) changing the amounts related to the Company's financial covenants regarding specified quarterly adjusted EBITDA requirements, as defined and described below. The Third Amended New Revolving Line of Credit allows for potential maximum aggregate advances of $35.0 million. The amount available is: (a) the lesser of (i) the Third Amended New Revolving Line of Credit or (ii) the amount available under the borrowing base, as determined by lender; minus (b) the outstanding principal balance of any advances. All cash collections from accounts receivable directly reduce the outstanding balance of the revolving credit facility. As of September 30, 2016, the Company had approximately $0.9 million of availability under the line of credit. The effective interest rate for the Third Amended New Revolving Line of Credit was 4.00% as of September 30, 2016. The loan is secured by substantially all of the Company's assets. Under the terms of the Third Amended New Loan and Security Agreement, the Company is required to meet and maintain certain customary financial and nonfinancial covenants, one of which restricts the Company’s ability to pay any dividends or make any distribution or payment to redeem, retire or purchase any capital stock, subject to certain specified exceptions. The Company must also maintain with the lender all of its primary domestic operating and other deposit and investment accounts consisting of at least 95% of the Company’s total cash and cash equivalents. This agreement also includes customary subjective acceleration clauses; in addition, the Company is required to comply with certain financial covenants, including the following: Adjusted EBITDA. The Company is required to maintain specified quarterly Adjusted EBITDA, which is defined for this purpose, with respect to any trailing twelve-month period, as an amount equal to the sum of net income, plus (a) interest expense, plus (b) to the extent deducted in the calculation of net income, depreciation expense and amortization expense, plus (c) income tax expense, plus or minus (d) change in deferred revenue, less, (e) capitalized software development expenses, plus (f) any non-cash items such as stock-compensation expense (and other mutually agreed upon non-cash items), plus one-time non-recurring charges subject to the lenders approval. This covenant is tested on a quarterly basis. Adjusted Quick Ratio. The Company is required to maintain at all times a 1.0 monthly minimum Adjusted Quick Ratio, which is defined as the ratio of cash held at the lender and cash equivalents plus net accounts receivables to current liabilities (including all debt outstanding under the Third Amended New Revolving Line of Credit) minus the current portion of deferred revenue. This covenant is tested on a monthly basis. There were no modifications to any other significant terms with the Third Amended New Loan and Security Agreement. As of September 30, 2016, the Company was in compliance with all financial and nonfinancial covenants. |
Common Stock Reserved for Issuance |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Reserved for Issuance | Common Stock Reserved for Issuance The Company’s shares of common stock reserved for issuance as of December 31, 2015 and September 30, 2016 were as follows:
|
Stock-Based Compensation |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation Equity Incentive Plans Prior to the closing of the Company's initial public offering on March 11, 2015 ("IPO"), the Company had a stock-based compensation plan, the 2010 Equity Incentive Plan (the "2010 Plan") under which the Company granted options to purchase shares of common stock to employees, directors and consultants. In January 2015, the Company’s board of directors adopted the 2015 Equity Incentive Plan (the "2015 Plan"), which was subsequently ratified by its stockholders in February 2015. The 2015 Plan is the successor to and continuation of the 2010 Plan. No additional awards are to be granted under the 2010 Plan, but all stock awards granted under the 2010 Plan remain subject to their existing terms. The 2015 Plan provides for the grant of the following awards: (i) incentive and nonstatutory stock options; (ii) stock appreciation rights; (iii) restricted shares; (iv) stock units; and (v) performance cash awards. As of September 30, 2016, 167,624 shares are available for future grants to employees, non-employee directors, consultants and advisors under the 2015 Plan. Stock Options The terms of the stock options, including the exercise price per share and vesting provisions, are determined by the board of directors. Historically, stock options were granted at exercise prices not less than the estimated fair market value of the Company’s common stock at the date of grant based upon numerous objective and subjective factors including: third-party valuations, preferred stock transactions with third-parties, current operating and financial performance, management estimates and future expectations. Subsequent to the completion of the IPO, the fair value of the Company's common stock on the grant date has been equal to the most recent closing price of the Company's stock on the New York Stock Exchange, or beginning May 13, 2016, on the Nasdaq. Stock option grants typically vest upon the expiration of an initial one year cliff and vest monthly thereafter over the remaining thirty-six months assuming continuing service, and expire ten years from the grant date. Stock-based compensation expense related to stock options is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
The Company accounts for stock options granted to employees based on their estimated fair values on the date of grant. The fair value of each stock option granted is estimated using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the risk-free interest rate, expected life, expected stock price volatility and dividend yield. The risk-free interest rate assumption is based upon observed interest rates for constant maturity U.S. Treasury securities consistent with the expected term of the Company’s employee stock options. The expected life represents the period of time the stock options are expected to be outstanding and is based on the simplified method. The Company uses the simplified method due to the lack of sufficient historical exercise data to provide a reasonable basis upon which to otherwise estimate the expected life of the stock options. Expected volatility is based on historical volatilities for publicly traded stock of comparable companies over the estimated expected life of the stock options. The Company assumes no dividend yield, which is consistent with the Company’s history of not paying dividends. The stock-based compensation expense is recognized on a straight-line basis over the requisite service period, net of estimated forfeitures. The following table summarizes the assumptions used for estimating the fair value of stock options granted to employees for the three and nine months ended September 30:
The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2016:
The weighted-average grant date fair value for the Company’s stock options granted was $10.80 and $4.25 per share during the three months ended September 30, 2015 and 2016, respectively. The weighted-average grant date fair value for the Company’s stock options granted was $13.32 and $3.92 per share during the nine months ended September 30, 2015 and 2016, respectively. The total compensation cost related to unvested stock options not yet recognized as of September 30, 2016 was $6.6 million and will be recognized over a weighted-average period of approximately 1.13 years. The aggregate intrinsic value of stock options exercised during the three and nine months ended September 30, 2015 was $0.1 million and $3.6 million, respectively. The aggregate intrinsic value of stock options exercised during the three and nine months ended September 30, 2016 was $0.1 million and $0.2 million, respectively. There was no associated income tax benefit recognized for the three and nine months ended September 30, 2015 and 2016 based on the Company’s valuation allowance that is recorded against its net deferred tax assets. Restricted Stock Units The terms of the restricted stock units ("RSUs"), including the vesting provisions, are determined by the board of directors. Each restricted stock unit represents the contingent right to receive one share of common stock of the Company. The RSUs granted typically vest over a two-year term upon the expiration of an initial six months cliff period and vest quarterly thereafter assuming continuing service. The Company accounts for RSUs granted to employees based on their estimated fair values on the date of grant. The fair value of RSUs is estimated based on the closing price of the underlying common stock on the date of grant. Stock-based compensation expense related to the RSUs is recognized on a straight-line basis over the requisite service period, net of estimated forfeitures. The Company initially granted RSUs during the three and nine months ended September 30, 2016. Stock-based compensation expense related to RSUs is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
The following table summarizes the Company’s restricted stock unit activity for the nine months ended September 30, 2016:
The total compensation cost related to nonvested RSUs not yet recognized as of September 30, 2016 was $4.7 million and will be recognized over a weighted-average period of approximately 1.13 years. Employee Stock Purchase Plan In January 2015, the Company’s board of directors adopted the 2015 Employee Stock Purchase Plan (the "2015 ESPP"), which was subsequently ratified by its stockholders in February 2015. The 2015 ESPP allows eligible employees to purchase shares of common stock at a discount through payroll deductions of up to 15% of their eligible compensation, subject to limitations set forth in the 2015 ESPP. Unless otherwise determined by the compensation committee, two offering periods of six months’ duration will begin each year on May 1 and November 1. Due to the timing of the Company's IPO, the first offering period started on March 5, 2015 and ended on October 30, 2015. At the end of each offering period, employees are able to purchase shares at the lower of 85% of the fair market value of the common stock on the first day of an offering period or on the purchase date. The Company has accumulated employee withholdings of $0.4 million as of September 30, 2016 associated with the next purchase date. Stock-based compensation expense related to the 2015 ESPP is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
The Company accounts for shares to be issued under its employee stock purchase plan based on the fair value of the shares determined using the Black-Scholes option pricing model on the first day of the offering period. The fair value of the "look back" option for 2015 ESPP shares issued during the offering period is estimated using: (1) a 15% discount on the purchase of the stock; (2) 85% of the fair value of the call option; and (3) 15% of the fair value of the put option. Stock-based compensation expense related to the employee stock purchase plan is recognized on a straight-line basis over the offering period, net of estimated forfeitures. The following table summarizes the assumptions used in the Black-Scholes option pricing model for estimating the fair value of employee stock purchase rights under the 2015 ESPP for the three and nine months ended September 30, 2016:
As of September 30, 2016, the total unrecognized stock-based compensation cost related to the 2015 ESPP was $0.01 million and will be recognized over a period of approximately 0.1 years. |
Commitments and Contingencies |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation The Company is subject to various legal matters and claims in the ordinary course of business. Although the results of legal proceedings and claims cannot be predicted with certainty, including the matters noted below, in the opinion of management, there are currently no such known matters that will have a material effect on the financial condition, results of operations or cash flows of the Company. The Company, certain of its officers and directors, and certain investment banking firms who acted as underwriters in connection with the Company’s IPO, have been named as defendants in a putative class action lawsuit filed August 31, 2015 in the United States District Court for the Southern District of New York. The complaint alleges that the defendants violated Sections 11, 12 and 15 of the Securities Act by not including information regarding customer concentration, which the complaint characterizes as a known trend and/or significant factor required to be disclosed under federal securities regulations. The complaint seeks unspecified damages, interest and other costs. The Court appointed a Lead Plaintiff on November 18, 2015, and on January 19, 2016 the Lead Plaintiff filed a First Amended Complaint that repeats the same substantive allegations included in the initial complaint and continues to seek unspecified damages. On March 24, 2016, the Company filed a motion to dismiss the First Amended Complaint. The Lead Plaintiff filed an opposition to that motion on May 9, 2016, and the Company filed a reply brief on June 8, 2016. A hearing date for the Company’s motion to dismiss has not yet been set, however, the Court may rule on the motion without hearing oral arguments. The Company disputes these claims and is defending this matter vigorously, and is unable to estimate the amount of a potential loss or range of potential loss, if any. Legal fees are expensed in the period in which they are incurred. Purchase Commitments The Company has $3.3 million of non-cancelable contractual commitments as of September 30, 2016, primarily related to purchases of data, third-party data centers and other support services. Of these commitments, $3.0 million and $0.3 million are due within the next year and within the next two years, respectively. Indemnification Agreements In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with directors and certain officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. Under certain circumstances, the Company’s indemnification obligations may include the cost of advancing legal expenses and indemnifying its officers, directors and underwriters for costs arising out of the litigation described above under "Commitments and Contingencies—Litigation," to the extent such costs are not covered by the Company’s directors’ and officers’ liability insurance. There are no claims that the Company is aware of that could have a material effect on the Company’s financial position, results of operations or cash flows. |
Earnings Per Share |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share The Company calculates net loss per basic share by dividing net loss by the weighted-average number of shares outstanding during the reporting period. The Company calculates net loss per diluted share by dividing net loss by the weighted-average number of shares outstanding during the reporting period plus the effects of any dilutive common stock-based instruments. Due to the net losses for the three and nine months ended September 30, 2015 and 2016, basic and diluted loss per share were the same, as the effect of potentially dilutive securities would have been anti-dilutive. The following securities have been excluded from the calculation of weighted-average common shares outstanding because the effect is anti-dilutive for the three and nine months ended September 30:
|
Related Party |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Related Party Transactions [Abstract] | |
Related Party | Related Party On August 15, 2015, the Company entered into an advisor agreement with Kevin Dulsky, a non-employee board member. Mr. Dulsky agreed to consult with and advise the Company from time to time, at the Company’s request, on business development and strategic planning matters. Mr. Dulsky was paid an hourly fee for his services provided, in addition to reimbursement for reasonable expenses. The agreement allowed Mr. Dulsky or the Company to terminate the advisor relationship at any time by giving the other party fifteen days’ notice. As of December 31, 2015, this advisor agreement had been terminated. For the three and nine months ended September 30, 2015, the Company incurred $0.02 million of expense related to this agreement that is classified in general and administrative expenses within the condensed consolidated statement of operations. As of December 31, 2015, there were no amounts due to Mr. Dulsky under this agreement. |
Summary of Significant Accounting Policies (Policies) |
9 Months Ended |
---|---|
Sep. 30, 2016 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary and have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany accounts and transactions have been eliminated in consolidation. |
Basis of Presentation and Unaudited Interim Condensed Consolidated Financial Information | Unaudited Interim Condensed Consolidated Financial Information The condensed consolidated financial statements and footnotes have been prepared in accordance with GAAP as contained in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") and applicable rules and regulations of the Securities and Exchange Commission’s ("SEC") Rule 10-01 of Regulation S-X for interim financial information. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of financial position, the results of operations, comprehensive loss, changes in stockholders’ equity and cash flows. The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the results for the full year or the results for any future periods. The accompanying condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015 ("Form 10-K"). The significant accounting policies and recent accounting pronouncements were described in Note 2 to the consolidated financial statements included in the Form 10-K. There have been no significant changes in or updates to the accounting policies since December 31, 2015 Basis of Presentation The condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company believes that its existing cash balances, together with its current revolving line of credit, which was recently amended to, among other things, extend the maturity date to December 31, 2017, will be sufficient to meet its anticipated cash requirements through at least the next 12 months. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. The Company evaluates its estimates, including those related to its allowance for doubtful accounts, revenue recognition, internal-use software, stock-based compensation, income taxes and related valuation allowances and the fair value of common stock warrants. The Company bases its estimates on its historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Actual results could differ from those estimates. |
Restricted Cash | Restricted Cash Restricted cash represents cash that is subject to contractual withdrawal restrictions and penalties. Restricted cash is classified within the condensed consolidated balance sheets based on the timing of when the restrictions are expected to lapse. The Company presented restricted cash related to its debt agreement in the condensed consolidated balance sheets based on timing of maturity. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and accounts receivable. All of the Company’s cash and cash equivalents are held at financial institutions that management believes to be of high credit quality. The Company’s cash and cash equivalent accounts exceed federally insured limits. The Company has not experienced any losses on cash and cash equivalents to date. To manage accounts receivable risk, the Company evaluates and monitors the creditworthiness of its customers. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts The Company extends credit to its customers without requiring collateral. Accounts receivable are stated at net realizable value. The Company utilizes the allowance method to provide for doubtful accounts based on management’s evaluation of the collectability of amounts due. The Company’s estimate is based on historical collection experience and the current status of accounts receivable. Historically, actual write-offs for uncollectible accounts have not significantly differed from the Company’s estimates. |
Internal-Use Software Development Costs | Internal-Use Software Development Costs The Company capitalizes certain costs associated with software developed for internal use, primarily consisting of direct labor costs associated with creating the software. Software development projects generally include three stages: the preliminary project stage (all costs are expensed as incurred); the application development stage (certain costs are capitalized and certain costs are expensed as incurred); and the post-implementation/operation stage (all costs are expensed as incurred). Costs capitalized in the application development stage primarily include costs of designing, coding and testing the software. Capitalization of costs requires judgment in determining when a project has reached the application development stage and the period over which the Company expects to benefit from the use of that software. Once the software is placed in service, these capitalized costs are amortized using the straight-line method over the estimated useful life of the software. |
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted | Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. This accounting standards update is to simplify the presentation of debt issuance cost. This new guidance requires that debt issuance cost related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the treatment of debt discounts. The accounting standards update does not affect the recognition and measurement guidance for debt issuance costs. In August 2015, the FASB issued ASU 2015-15, Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. This accounting standards update states that given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line of credit arrangements, the SEC would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the debt issuance costs ratably over the term of the line of credit arrangement, regardless of whether there are any outstanding borrowings on the line of credit arrangement. The Company adopted ASU 2015-03, effective January 1, 2016, on a retrospective basis. The adoption of these pronouncements did not have a material impact on the Company's consolidated results of operations, financial position or cash flows. Recent Accounting Pronouncements Not Yet Adopted In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. The new standard provides a single principles-based, five-step model to be applied to all contracts with customers, which steps are to (1) identify the contract(s) with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when each performance obligation is satisfied. More specifically, revenue will be recognized when promised goods or services are transferred to the customer in an amount that reflects the consideration expected in exchange for those goods or services. This guidance states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09 for all entities by one year. In March 2016, the FASB issued ASU 2016-08, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU 2016-10, which clarifies the implementation guidance on identifying performance obligations and licensing. In May 2016, the FASB issued ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, which rescinds SEC paragraphs pursuant to SEC staff announcements. These rescissions include changes to topics pertaining to accounting for shipping and handling fees and costs and accounting for consideration given by a vendor to a customer. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, which amends certain aspects of the new revenue recognition standard pursuant to ASU 2014-09. ASU 2014-09, as amended by ASU 2015-14, is effective for interim or annual periods beginning after December 15, 2017. Early adoption of the standard is permitted, but not before the original effective date. Companies can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company plans to adopt ASU 2014-09 as of January 1, 2018. The Company is currently in the process of evaluating the impact that the adoption of ASU 2014-09 will have on its consolidated results of operations, financial position and cash flows, and selecting the method of transition to the new standard. In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. This guidance addresses management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim periods within annual periods beginning after December 15, 2016. Although early adoption was permitted, the Company did not early adopt this standard. The Company is currently evaluating the impact the update will have on its consolidated financial statements and related disclosures. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. This accounting standards update simplifies the presentation of deferred income taxes by eliminating the current requirement for an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. ASU 2015-17 requires an entity to classify deferred income tax liabilities and assets, as well as any related valuation allowance, as noncurrent within a classified balance sheet. This accounting standards update becomes effective for interim or annual periods beginning after December 15, 2016, and can be applied retrospectively or prospectively. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The purpose of this guidance is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance supersedes previous accounting guidance under Topic 840. Under ASU 2016-02, a lessee will be required to recognize assets and liabilities for the rights and obligations created by leases for leases with lease terms of more than 12 months. Lessor accounting remains substantially similar to current GAAP. In addition, disclosures of leasing activities are to be expanded to include qualitative along with specific quantitative information. ASU 2016-02 is effective for interim or annual periods beginning after December 15, 2018 and early adoption is permitted. This standard requires lessees and lessors to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for interim or annual periods beginning after December 15, 2016 and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments. This new standard provides guidance related to eight specific cash flow issues, with the objective of reducing diversity in practice of how certain cash receipts and payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for interim or annual periods beginning after December 15, 2017 and early adoption is permitted. ASU 2016-15 must be applied retrospectively, unless it is impracticable to do so, in which case the amendments would be applied prospectively as of the earliest date practicable. The Company does not expect to early adopt this guidance and is currently evaluating the impact of the adoption of this guidance on its consolidated results of operations, financial position and cash flows. |
Fair Value Measurements | The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued expenses and other current liabilities, approximate their respective fair values due to their short term nature. The Company's debt contains a variable rate of interest as of September 30, 2016 and therefore the carrying value of debt approximates its fair value. The fair value of debt falls within Level 3 of the fair value hierarchy as it is significantly driven by the creditworthiness of the Company, which is an unobservable input. |
Stock-Based Compensation | The Company accounts for RSUs granted to employees based on their estimated fair values on the date of grant. The fair value of RSUs is estimated based on the closing price of the underlying common stock on the date of grant. Stock-based compensation expense related to the RSUs is recognized on a straight-line basis over the requisite service period, net of estimated forfeitures. The Company accounts for stock options granted to employees based on their estimated fair values on the date of grant. The fair value of each stock option granted is estimated using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the risk-free interest rate, expected life, expected stock price volatility and dividend yield. The risk-free interest rate assumption is based upon observed interest rates for constant maturity U.S. Treasury securities consistent with the expected term of the Company’s employee stock options. The expected life represents the period of time the stock options are expected to be outstanding and is based on the simplified method. The Company uses the simplified method due to the lack of sufficient historical exercise data to provide a reasonable basis upon which to otherwise estimate the expected life of the stock options. Expected volatility is based on historical volatilities for publicly traded stock of comparable companies over the estimated expected life of the stock options. The Company assumes no dividend yield, which is consistent with the Company’s history of not paying dividends. The stock-based compensation expense is recognized on a straight-line basis over the requisite service period, net of estimated forfeitures. The Company accounts for shares to be issued under its employee stock purchase plan based on the fair value of the shares determined using the Black-Scholes option pricing model on the first day of the offering period. The fair value of the "look back" option for 2015 ESPP shares issued during the offering period is estimated using: (1) a 15% discount on the purchase of the stock; (2) 85% of the fair value of the call option; and (3) 15% of the fair value of the put option. Stock-based compensation expense related to the employee stock purchase plan is recognized on a straight-line basis over the offering period, net of estimated forfeitures. |
Earnings Per Share | The Company calculates net loss per basic share by dividing net loss by the weighted-average number of shares outstanding during the reporting period. The Company calculates net loss per diluted share by dividing net loss by the weighted-average number of shares outstanding during the reporting period plus the effects of any dilutive common stock-based instruments. |
Summary of Significant Accounting Policies (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in the allowance for doubtful accounts | The following table presents the changes in the allowance for doubtful accounts for the three and nine months ended September 30 (in thousands):
|
Common Stock Reserved for Issuance (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of common stock reserved for issuance | The Company’s shares of common stock reserved for issuance as of December 31, 2015 and September 30, 2016 were as follows:
|
Stock-Based Compensation (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of stock-based compensation expense | Stock-based compensation expense related to RSUs is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
Stock-based compensation expense related to the 2015 ESPP is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
Stock-based compensation expense related to stock options is included in the following line items in the condensed consolidated statements of operations for the three and nine months ended September 30 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the assumptions used for estimating the fair value of stock options granted to employees | The following table summarizes the assumptions used for estimating the fair value of stock options granted to employees for the three and nine months ended September 30:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of stock option activity | The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2016:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the assumptions used for estimating the fair value of shares to be granted under the 2015 ESPP | The following table summarizes the assumptions used in the Black-Scholes option pricing model for estimating the fair value of employee stock purchase rights under the 2015 ESPP for the three and nine months ended September 30, 2016:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of restricted stock unit activity | The following table summarizes the Company’s restricted stock unit activity for the nine months ended September 30, 2016:
|
Earnings Per Share (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of anti-dilutive securities which are excluded from the calculation of weighted average common shares outstanding | The following securities have been excluded from the calculation of weighted-average common shares outstanding because the effect is anti-dilutive for the three and nine months ended September 30:
|
Description of Business - Organization (Details) |
Sep. 30, 2016
office
|
---|---|
United Kingdom | |
Entity Location [Line Items] | |
Number of offices | 1 |
Description of Business - Reverse Stock Split (Details) |
Apr. 25, 2016 |
---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Stock split conversion ratio | 0.25 |
Description of Business - Stock Repurchase Program (Details) - Common Stock - USD ($) $ / shares in Units, $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2016 |
Mar. 04, 2016 |
|
Equity, Class of Treasury Stock [Line Items] | ||
Amount of stock repurchase program authorized (up to) | $ 4.0 | |
Number of shares repurchased (in shares) | 15,197 | |
Weighted average price per share of shares repurchased (in usd per share) | $ 8.19 | |
Amount available for common stock repurchases under the program | $ 3.9 |
Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($) |
Sep. 30, 2016 |
Mar. 07, 2016 |
Dec. 31, 2015 |
---|---|---|---|
Compensating Balances [Line Items] | |||
Restricted cash, short-term | $ 0 | $ 1,861,000 | |
Amended New Loan and Security Agreement | |||
Compensating Balances [Line Items] | |||
Restricted cash, short-term | 1,900,000 | ||
Available borrowing capacity | $ 900,000 | $ 3,100,000 | |
Amended New Loan and Security Agreement | Minimum | |||
Compensating Balances [Line Items] | |||
Minimum amount required to be maintained by the company at all times | $ 5,000,000 |
Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Allowance for doubtful accounts: | ||||
Balance, beginning of period | $ 315 | $ 159 | $ 102 | $ 179 |
Add: adjustment for bad debts | (4) | 177 | 324 | 177 |
Less: write-offs, net of recoveries | (1) | (13) | (116) | (33) |
Balance, end of period | $ 310 | $ 323 | $ 310 | $ 323 |
Summary of Significant Accounting Policies - Internal-Use Software Development Costs (Details) - Capitalized internal-use software costs - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Dec. 31, 2015 |
|
Internal-Use Software Development Costs | |||||
Capitalized development costs | $ 1.7 | $ 1.6 | $ 5.5 | $ 4.7 | |
Amortization expense | 1.3 | $ 0.6 | 3.5 | $ 1.8 | |
Net book value | $ 11.7 | $ 11.7 | $ 9.8 |
Fair Value Measurements (Details) $ in Millions |
Dec. 31, 2015
USD ($)
|
---|---|
Level 1 | Money Market Fund | |
Assets: | |
Cash and cash equivalents - Money Market Fund | $ 18.6 |
Common Stock Reserved for Future Issuance (Details) - shares |
Sep. 30, 2016 |
Dec. 31, 2015 |
---|---|---|
Common Stock Reserved for Issuance | ||
Total shares reserved | 1,896,432 | 1,565,251 |
2015 Employee Stock Purchase Plan | ||
Common Stock Reserved for Issuance | ||
Total shares reserved | 93,325 | 60,318 |
Equity Incentive Plans | ||
Common Stock Reserved for Issuance | ||
Total shares reserved | 167,624 | 380,460 |
Stock Options | ||
Common Stock Reserved for Issuance | ||
Total shares reserved | 1,047,078 | 1,074,473 |
Unvested restricted stock units | ||
Common Stock Reserved for Issuance | ||
Total shares reserved | 538,405 | 0 |
Lender warrants to purchase common stock | ||
Common Stock Reserved for Issuance | ||
Total shares reserved | 50,000 | 50,000 |
Stock-Based Compensation - Equity Incentive Plan Terms (Details) |
9 Months Ended |
---|---|
Sep. 30, 2016
shares
| |
Equity Incentive Plans | Stock options | |
Award terms | |
Term of grant (in years) | 10 years |
Equity Incentive Plans | Initial Cliff Period | Stock options | |
Award terms | |
Vesting period | 1 year |
Equity Incentive Plans | Remaining Vesting Period | Stock options | |
Award terms | |
Vesting period | 36 months |
2015 Equity Incentive Plan | |
Stock-Based compensation | |
Shares available for future grants | 167,624 |
2015 Equity Incentive Plan | Restricted stock units | |
Award terms | |
Vesting period | 2 years |
2015 Equity Incentive Plan | Initial Cliff Period | Restricted stock units | |
Award terms | |
Vesting period | 6 months |
Stock-Based Compensation - Fair Value Assumptions, Stock Options (Details) - Employee Stock Options |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Fair Value Assumptions using Black-Scholes option pricing model | ||||
Risk free interest rate, minimum | 1.16% | 1.57% | 1.16% | 1.57% |
Risk free interest rate, maximum | 1.33% | 1.76% | 1.53% | 1.87% |
Expected term (years) | 6 years 29 days | 6 years 29 days | 6 years 29 days | |
Expected volatility, minimum | 58.00% | 46.00% | 53.00% | |
Expected volatility, maximum | 59.00% | 47.00% | 59.00% | |
Expected volatility | 46.00% | |||
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% |
Minimum | ||||
Fair Value Assumptions using Black-Scholes option pricing model | ||||
Expected term (years) | 6 years 11 days | |||
Maximum | ||||
Fair Value Assumptions using Black-Scholes option pricing model | ||||
Expected term (years) | 6 years 29 days |
Stock-Based Compensation - Additional Disclosures, Stock Options (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Stock-Based compensation | ||||
Weighted-average grant date fair value (in usd per share) | $ 4.25 | $ 10.80 | $ 3.92 | $ 13.32 |
Unrecognized compensation cost related to nonvested share-based compensation arrangements | $ 6.6 | $ 6.6 | ||
Intrinsic value of options exercised | $ 0.1 | $ 0.1 | $ 0.2 | $ 3.6 |
Stock options | ||||
Stock-Based compensation | ||||
Expected weighted-average period for recognition of unrecognized stock-based compensation costs (in years) | 1 year 1 month 17 days |
Stock-Based Compensation - Restricted Stock Unit Activity (Details) - Restricted stock units |
9 Months Ended |
---|---|
Sep. 30, 2016
$ / shares
shares
| |
Number of Shares | |
Nonvested balance at beginning of period (in shares) | shares | 0 |
Granted (in shares) | shares | 540,420 |
Vested (in shares) | shares | 0 |
Forfeited (in shares) | shares | (2,015) |
Nonvested balance at end of period (in shares) | shares | 538,405 |
Weighted Average Grant Date Fair Value | |
Nonvested balance at beginning of period (in usd per share) | $ / shares | $ 0.00 |
Granted (in usd per share) | $ / shares | 8.87 |
Vested (in usd per share) | $ / shares | 0.00 |
Forfeited (in usd per share) | $ / shares | 8.87 |
Nonvested balance at end of period (in usd per share) | $ / shares | $ 8.87 |
Stock-Based Compensation - Employee Stock Purchase Plan (Details) - 2015 Employee Stock Purchase Plan $ in Millions |
1 Months Ended | 9 Months Ended |
---|---|---|
Jan. 31, 2015
offering_period
|
Sep. 30, 2016
USD ($)
|
|
Stock-Based compensation | ||
Maximum percentage of eligible compensation per employee to purchase shares of common stock | 15.00% | |
Number of offering periods under terms of plan | offering_period | 2 | |
Offering periods beginning on May 1 and November 1 | 6 months | |
Employee purchase price, percentage of fair market value of common stock | 85.00% | |
Accumulated employee withholdings | $ | $ 0.4 | |
Discount on purchase of stock (as a percent) | 15.00% | |
Call Option | ||
Stock-Based compensation | ||
Fair value of option (as a percent) | 85.00% | |
Put Option | ||
Stock-Based compensation | ||
Fair value of option (as a percent) | 15.00% |
Stock-Based Compensation - Fair Value Assumptions, ESPP (Details) - 2015 Employee Stock Purchase Plan |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Stock-Based compensation | ||||
Risk-free interest rate | 0.41% | 0.10% | 0.10% | |
Risk free interest rate, minimum | 0.27% | |||
Risk free interest rate, maximum | 0.41% | |||
Expected term (years) | 6 months | 7 months 2 days | 6 months | 7 months 2 days |
Expected volatility | 43.00% | 61.00% | 61.00% | |
Expected volatility, minimum | 43.00% | |||
Expected volatility, maximum | 55.00% | |||
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% |
Commitments and Contingencies (Details) $ in Millions |
Sep. 30, 2016
USD ($)
|
---|---|
Commitments and Contingencies Disclosure [Abstract] | |
Total contractual commitments | $ 3.3 |
Commitments due within next year | 3.0 |
Commitments due within one to two years | $ 0.3 |
Related Party (Details) - Kevin Dulsky - USD ($) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Aug. 15, 2015 |
Sep. 30, 2015 |
Sep. 30, 2015 |
Dec. 31, 2015 |
|
Related party transactions | ||||
Termination of agreement, notice period | 15 days | |||
Accounts payable related to advisor agreement | $ 0 | |||
General and administrative | ||||
Related party transactions | ||||
Expense incurred related to advisor agreement | $ 20,000 | $ 20,000 |
FB2V0E5;(U)YJ@J3ZBZ/T5;B/\#
M,6@P3QA\8/FR4_;5+07:QW>J;L+@PZ@'^2(=HE!DGA#Y,*K+(*)099Y0N5<$
MCJ67H]<\X74_"HLO1]/YL:9S-)VCZ3QA^H&RQTZN91!*(PI-YPG38_FC'%\N
MG>P@[%&ZYB<)*PA'TWG"],.+YK8-+ *C!-'!U+2NQU'-2%=Y[.NS2^R5=XD7>\@5_<-$); 1$GN3!G7AG:?SD:7")6^\+?ZCWY6%2^ZWX5RG?VI]*1__2=?L5LB>/GS]XW)ETM_S5KQ%(6O_.=.FJUQ/=V
M8I^="_4B+]]%GT/<=KB516.NWO;<*%E^4GROS#ZZ>UZ9^Z7[DI*>AA/"GA .
M!'J;P'H"^R*PFX2H)T0#(4QN$N*>$ \$=IO >P+_BF!R"+IBF5*O,I7-I[6\
M>'4W/TY9.PWI$]>#N6T;S=B9;[K8C6Y]GZ?I-'AO^^DABPX2CB$3&[)T(1-B
M0U8(A-J0-0();<@&@; !$NA,AW1#--W0\*,Q/P+I=A!N()6!\)B329J G._C
M+#T,U<-3'0TT&249R8)HP!-2X*5'>%( BC%*2_=F$/*1P%!!-31@B>>81F
M'ID^V#ASCO-CE!^[E0,CM(B=$0KU\(#Z+N^A+"T7.N 2C$]TI.XB?67W(J\9[E4H?#LT1;B^E$KI/\JC'^JC_(X:70NQ5^YCH
MY[H[67&PO
M=V]R:W-H965TDC;\G]E04/MX_!;.=ARIT?#8
MW3[(_$N+_U!+ P04 " *AFI)V476[J ! "Q P &0 'AL+W=O
673DDXTK',XJ0[N%V^?>U!##.)G0P:QF#O:_(FQ-[WX7AY<
MJ#T02@JI); :KN1(*-5**O/O2?0CIR8NYS?UKZ9<9?^$!3DR^JLI9:W<0M8W(+Y@,"E,G9J6]UZAL^NLL1V06050 9
M@6 A@."JTA$2&TAG("M$OD5X2>1!".U. JN38./$1[%=(+0*A(_W(K(*1/_M
M13Y"HF6E.PC_66ELS1-;*DU638\W+5WE&?UL8F%O^HF2.0,(W9QQ%Z$H#-3/_="'BK
M 0ZFD/Z1(DV,1[U5RL8\]L*(&MW5;#K/&B?5RK- )$,[*II(_P-_(:$(E
MRDB;&>?.QD4XX>^<'F+RT]FCJVFU4GS%:EN'#X?UMEM#XJ666^,=Z6(KRRM7
MX][$3C"B^5UWU0 A5\ =>GOH(N3%:H.(3@&/G&2$V>YB7**T+I1Y3%3BINAX
MW090^DU*J;PP H73@(1*1?)VYK&,(\MW.W-<>K$0\UZT_:AYM%5P.]NW]V;/
M%HN2T_'!3P8.E@3Y!:FW*, R=G!X3B-ZZ@!Z7*(Y9C\0+.SG$57:496V=2
MF@2B5MY*WJY P#F6?@M<5Z%Y?&&)!B[V ;?'F=)^Q!BV9.SJB,2N8:J4N)&J
M4*DWA188R28RR*&^CYR,)&U,C*V6+,]E 7JEE "<;[P KX+X@C8P5'P6!AC=
MA\\HW-99X+!L58J_&U[8R,B.G*DM5